search indicatorNeed Help?

Books by Subject

all 191 titles

Infectious DiseasesAccess restricted to Stanford unless otherwise noted

  • The global AIDS transition: a feasible objective for AIDS policy -- Using incentives to prevent HIV infections -- Sustaining and leveraging AIDS treatment -- Appendix A. Alternative approaches to estimating the average cost of antiretroviral treatment -- Appendix B. A meta-analysis of the health benefits of early initiation of antiretroviral therapy -- Appendix C. A model for projecting future AIDS treatment costs.
  • Pt. 1. General properties of antimicrobial agents -- Pt. 2. Resistance to antimicrobial agents -- Pt. 3. General principles of usage of antimicrobial agents -- Pt. 4. Therapeutic use of antimicrobial agents.
  • Antimicrobial drug resistance v. 1-2, 2009., Springer
    v. 2, 2009 Springer
    v. 1. Mechanisms of drug resistance -- v. 2. Clinical and epidemiological aspects.
  • Community-associated methicillin resistant staphylococcus aureus / Miller, L.G. -- Infections with organisms producing extended-spectrum [beta]-lactamase / Paterson, D.L., Doi, Y. -- Fluoroquinolone resistance : challenges for disease control / Parry, C.M. -- Antibiotic resistance and community-acquired pneumonia during an influenza pandemic / Moore, M.R., Whitney, C.G. -- Promoting appropriate antimicrobial drug use in the outpatient setting : what works? / Belongia, E.A., Mangione-Smith, R., Knobloch, M.J. -- Reducing antimicrobial-resistant infections in health care settings : what works? / Rezai, K., Weinstein, R.A. -- Cost of antimicrobial resistance in healthcare settings : a critical review / Merz, L.R., Guth, R.M., Fraser, V.J. -- Mass treatment of parasitic disease : implications for the development and spread of anthelmintic resistance / Curcher, T.S. ... [et al.] -- Antifungal drug resistance : clinical importance, in vitro detection and implications for prophylaxis and treatment / Arthington-Skaggs, B.A., Frade, J.P. -- Preparing for HIV drug resistance in the developing world / Bennett, D.E.
  • Mechanisms of resistance by gram-positive bacteria (streptococci and enterococci) /Javier Aspa Marco ... [et al.] --Emergence of MRSA in the community /Adam L. Cohen, Rachel Gorwitz, and Daniel B. Jernigan --Antimicrobial resistance to sexually transmitted infections /Hillard Weinstock, David Trees, and John Papp --Resistance of gram-negative bacilli to antimicrobials /Patricia A. Bradford and Charles R. Dean --Mycobacterial antimicrobial resistance /Peter D.O. Davies and Richard Cooke --Antimicrobial resistance of anaerobic bacteria /Ellie J.C. Goldstein, Diane M. Citron, and David W. Hecht --Clinical significance and biological basis of HIV drug resistance /Jorge L. Martinez-Cajas, Marco Petrella, and Mark A. Wainberg --Resistance of herpesviruses to antiviral agents /G. Boivin and W.L. Drew --Hepatitis virus resistance /Jean-Michel Pawlotsky --Resistance to antifungal agents /Beth A. Arthington-Skaggs and John H. Rex --An anti-mutant approach for antimicrobial use /Karl Drlica ... [et al.]
  • General issues in antimicrobial resistance -- Global perspectives of antibiotic resistance -- Mechanisms of antimicrobial resistance -- Poverty and root causes of resistance in developing countries -- What the future holds for resistance in developing countries -- Introduction of antimicrobial agents in resource-constrained countries: impact on the emergence of resistance -- Human impact of resistance -- Human immunodeficiency virus: resistance to antiretroviral drugs in developing countries -- Drug resistance in malaria in developing countries -- Drug resistance in Mycobacterium tuberculosis -- Antifungal drug resistance in developing countries -- Drug resistance in African trypanosomiasis -- Antimicrobial resistance in enteric pathogens in developing countries -- Bacterial-resistant infections in resource-limited countries -- Prevalence of resistant enterococci in developing countries -- Antimicrobial resistance in gram-negative bacteria from developing countries -- Resistance in reservoirs and human commensals -- Antimicrobial use and misuse -- Determinants of antimicrobial use: poorly understood-poorly researched -- Antimicrobial use and resistance in Africa -- Antimicrobial drug resistance in Asia -- Antimicrobial drug resistance in Latin American and the Caribbean -- Hospital infections by antimicrobial-resistant organisms in developing countries -- Cost, policy, and regulation of antimicrobials -- Economic burden of antimicrobial resistance in the developing world -- Strengthening health systems to improve access to antimicrobials and the containment of resistance -- Role of unregulated sale and dispensing of antimicrobial agents on the development of antimicrobial resistance in developing countries -- Counterfeit and substandard anti-infectives in developing countries -- Strategies to contain antimicrobial resistance -- Containment of antimicrobial resistance in developing countries and lessons learned -- Surveillance of antibiotic resistance in developing countries: needs, constraints and realities -- Vaccines: a cost-effective strategy to contain antimicrobial resistance -- Teaching appropriate antibiotic use in developing countries -- Containing global antibiotic resistance: ethical drug promotion in the developing world -- News media reporting of antimicrobial resistance in Latin America and India.
  • Avian influenza 2008, Karger
    Epidemiology of avian influenza / Osterhaus, A.D.M.E., Munster, V.J., Fouchier, R.A.M. -- H5N1 in Asia / Yen, H.-L. ... [et al.] -- Epidemiology and control of H5N1 avian influenza in China / Chen, H., Bu, Z., Wang, J. -- Avian influenza in Northern Eurasia / Lvov, D.K., Kaverin, N.V. -- Avian influenza in Italy, 1997-2006 / Capua, I. ... [et al.] -- Avian influenza outbreaks in Germany : development of new avian vaccines / Werner, O. ... [et al.] -- The role of pigs in interspecies transmission / Brown, I.H. -- History of research on avian influenza / Scholtissek, C. -- Reverse genetics of influenza viruses : applications in research and vaccine design / Neumann, G., Horimoto, T., Kawaoka, Y. -- Receptor specificity of influenza viruses and its alteration during interspecies transmission / Matrosovich, M.N., Gambaryan, A.S., Klenk, H.-K. -- Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis / Garten, W., Klenk, H.-D. --Structure and function of the influenza A virus ribonucleoprotein : transcription and replication / Ortín, J. -- Influenza A virus polymerase : a determinant of host range and pathogenicity / Stech, J. -- Influenza A virus virulence and innate immunity : recent insights from new mouse models / Haller, O., Kochs, G., Staeheli, P. -- Signaling to life and death : influenza viruses and intracellular signal transduction cascades / Ludwig, S. ... [et al.] -- Cytokines in the pathogenesis of highly virulent influenza viruses in humans / Van Reeth, K. -- Antivirals and resistance / Hay, A.J., Collins, P.J., Russell, R.J. -- The 1918 influenza pandemic : lessons from the past raise questions for the future / Steel, J., Palese, P.
  • Microbial genomes / Voon Loong Chan -- Evolution and origin of virulence isolates / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Genomic approach to understanding of infectious disease mechanisms / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Knockout and disease models in toll-like receptor-mediated immunity / Huey-Lan Huang and Wen-Chen Yeh -- Campylobacter from glycome to pathogenesis / John Kelly ... [et al.] -- Genomics of helicobacter species / Zhongming Ge and David B. Schauer -- The organization of leptospira at a genomic level / Dieter M. Bulach ... [et al.] -- Listeria monocytogenes / Keith Ireton -- Mycobacterial genomes / David C. Alexander and Jun Liu -- Mycoplasma / Yuko Sasaki -- Genome comparisons of diverse staphylococcus aureus strains / Martin J. McGavin -- Type III secretion, systems in yersinia pestis, and yersinia pseudotuberculosis / James B. Bliska, Michelle B. Ryndak, and Jens P. Grabenstein -- Genomics and the evolution of pathogenic vibrio cholerae / William S. Jermyn ... [et al.] -- Future directions of infectious disease research / Philip M. Sherman, Billy Bourke, and Voon Loong Chan -- Index.
  • Epidemiological concepts / Alfred S. Evans -- Public health surveillance / Philip S. Brachman -- Molecular epidemiology / Lee W. Riley -- Epidemiology of bacterial resistance to antimicrobial agents / Fred C. Tenover and John E. McGowan, Jr. -- Anthrax / Philip S. Brachman and Arnold F. Kaufmann -- Bacterial foodborne disease / Heather Green ... [et al.] -- Botulism / Patricia A. Yu ... [et al.] -- Brucellosis / Edward J. Young -- Campylobacter infections / Ban Mishu Allos -- Chancroid / Jaffar A. Al-Tawfiq -- Chlamydial infections / Julius Schachter and E. Russell Alexander -- Cholera / Manoj P. Menon, Eric D. Mintz, and Robert V. Tauxe -- Clostridium difficile / Dale N. Gerding and Stuart Johnson -- Dipththeria / Melinda Wharton -- Escherichia coli diarrhea / Herbert L. DuPont, M. Teresa Estrada-Garcia, and Zhi-Dong Jiang -- Gonococcal infections / Jonathan M. Zenilman and J. McLeod Griffiss -- Haemophilus influenzae / Janet R. Gilsdorf -- Helicobacter pylori / Sharon Perry, Catherine de Martel, and Julie Parsonnet -- Legionellosis / Roopal Patel, Matthew R. Moore, and barry S. Fields -- Leprosy / Richard I. Frankel and David M. Scollard -- Leptospirosis / Paul N. Levett and Charles N. Edwards -- Listeria monocytogenes infections / Donald Armstrong and Donald B. Louria -- Lyme disease / Roger P. Clark and Linden T. Hu -- Meningococcal infections / Robert S. Baltimore -- Mycoplasma pneumoniae and other human mycoplasmas / Deborah F. Talkington and Ken B. Waites -- Healthcare-acquired bacterial infections / Ebbing Lautenbach and Elias Abrutyn -- Pertussis / Scott A. Halperin and Gaston De Serres -- Plague / David T. Dennis and J. Erin Staples -- Pneumococcal infections / Keith P. Klugman and Charles Feldman -- Q fever / Thomas J. Marrie -- Rocky mountain spotted fever / Aaron Milstone and J. Stephen Dumler -- Salmonellosis : nontyphoidal / Michael F. Lynch and Robert V. Tauxe -- Shigellosis / Gerald T. Keusch -- Evans' infections of humans: staphylococcal infections / Zeina A. Kanafani and Vance G. Fowler, Jr. -- Streptococcal infections / Barry M. Gray and Dennis L. Stevens -- Syphilis / Anne Rompalo and Willard Cates -- Nonvenereal treponematoses / Ammar M. Ahmed ... [et al.] -- Tetanus / Steven G.F. Wassilak and Katrina Kretsinger -- Toxic shock syndrome (staphylococcal) / Arthur L. Reingold -- Tuberculosis / Diana S. Pope, Richard E. Chaisson, and George W. Comstock -- Nontuberculous mycobacterial infections / Charles L. Daley -- Tularemia / Paul S. Mead and Jeannine M. Petersen -- Typhoid fever / Myron M. Levine -- Yersinia enterocolitica infections / Ann M. Schmitz and Robert V. Tauxe.
  • Epidemiology of healthcare-associated infections -- The healthcare epidemiologist -- Hand hygiene -- Personnel health services -- The development of infection surveillance and control programs -- Surveillance of healthcare-associated infections -- Investigating endemic and epidemic healthcare-associated infections -- Epidemiological methods for investigating infections in the healthcare setting -- Use of computerized systems in healthcare epidemiology -- The role of the laboratory in control of healthcare-associated infections -- The practice of epidemiology in community hospitals -- The role of professional and regulatory organizations in infection control -- Antimicrobial stewardship: programmatic efforts to optimize antimicrobial use -- Multiply drug-resistant pathogens: epidemiology and control -- Molecular biology of resistance -- Economic evaluation of healthcare-associated infections and infection control interventions -- Legal aspects of healthcare-associated infections -- Infection control: a global view -- The inanimate environment -- Sterilization and disinfection -- Foodborne disease prevention in healthcare facilities -- Clinical laboratory-acquired infections -- Dialysis-associated complications and their control -- The intensive care unit: part A. HAI epidemiology, risk factors, surveillance, engineering and administrative infection control practices, and impact -- The intensive care unit: part B. antibiotic resistance and prevention of CVC-BSIs, catheter-associated urinary tract infections and C. difficile -- The newborn nursery and the neonatal intensive care unit -- The operating room -- Ambulatory care setting -- Infections in long-term care facilities -- Incidence and nature of endemic and epidemic healthcare-associated infections -- Urinary tract infections -- Hospital-acquired pneumonia -- Tuberculosis -- Infectious gastroenteritis -- Central nervous system infections -- Surgical site infections -- Infections of burn wounds -- Infections due to infusion therapy -- Infections of implantable cardiac and vascular devices -- Infections in skeletal prostheses -- The importance of infection control in controlling antimicrobial-resistant pathogens -- Healthcare-associated respiratory viral infections -- Blood borne pathogen prevention -- Healthcare-associated fungal infections -- Infection in transplant recipients -- Miscellaneous procedure-related infections -- Public reporting of healthcare-associated infection rates -- Patient safety.
  • Biodefense 2006, CRCnetBASE
  • Microbial biofilms / Xiuping Jiang and John L. Pace -- Economic impact of biofilms on treatment costs / John G. Thomas, Isaiah Litton, and Harald Rinde -- Biofilm-related indwelling medical device infections / Matthew K. Schinabeck and Mahmoud A. Ghannoum -- Medical device composition and biological secretion influences on biofilm formation / Sean P. Gorman and David S. Jones -- Role of biofilms in infections caused by Escherichia coli / Grégory Jubelin, Corinne Dorel, and Philippe Lejeune -- Staphylococcus aureus biofilms / Julie M. Higashi and Paul M. Sullam -- Coagulase-negative staphylococci / Dietrich Mach ... [et al.] -- Pseudomonas aeruginosa biofilm infections in cystic fibrosis / Andrea Smiley and Daniel J. Hassett -- Candida / Stephen Hawser and Khalid Islam -- Current perspectives on the regulation of the ica operon and biofilm formation in Staphylococcus epidermidis / Paul D. Fey and Luke D. Handke -- Cell-to-cell communication in bacteria / Kenneth D. Tucker and Luciano Passador -- Persisters: specialized cells responsible for biofilm tolerance to antimicrobial agents / Kim Lewis ... [et al.] -- Minimal biofilm eradication concentration (MBEC) assay: susceptibility testing for biofilms / Howard Ceri ... [et al.] -- Environmental cues regulate virulence and biofilm formation / John L. Pace and Steven M. Frey -- In vivo models for the study of biomaterial-associated infection by biofilm-forming staphylococci / Luke D. Handke and Mark E. Rupp -- Host response to biofilms / Susan Meier-Davis -- Pharmacodynamics and the treatment of IMD-related infections / Roger Finch and Sarah Gander -- Protein synthesis inhibitors, fluoroquinolones, and rifampin for biofilm infections / Steven L. Barriere -- [beta][beta]-lactams for the treatment of biofilm-associated infections / Ingrid L. Dodge, Karen Joy Shaw, and Karen Bush -- Glycopeptide antibacterials and the treatment of biofilm-related infections / John L. Pace, Roasaire Verna, and Jan Verhoef -- Antibiotic resistance in biofilms / Nafsika H. Georgopapadakou -- Treatment protocols for infections of vascular catheters / Russell E. Lewis and Issam I Raad -- Treatment protocols for bacterial endocarditis and infection of electrophysiologic cardiac devices / Martin E. Stryjewski and G. Ralph Corey -- Treatment protocol of infections of orthopedic devices / Vera Antonios, Elie Berbari, and Douglas Osmon.
  • Department of defense capabilities supporting bioterrorism response -- Modeling for bioterrorism incidents -- Biological weapons defense: effect levels -- Pathogenesis by aerosol -- Bacillus anthracis and the pathogenesis of anthrax -- Virologic and pathogenic aspects of the variola virus (Smallpox) as a bioweapon -- Plague vaccines: retrospective analysis and future developments -- Medical protection against brucellosis -- Pathogenesis of and immunity to coxiella burnetii -- Glanders: new insights into an old disease -- Medical countermeasures for filoviruses and other viral agents -- Medical defense against protein toxin weapons: review and perspective -- Antimicrobials for biological warfare agents -- Nonspecific immunomodulator therapy: CpG -- Decontamination -- Definition and overview of emerging threats -- Department of defense global emerging infections system programs in biodefense -- Information resources and database development for defense against biological weapons -- Genomic efforts with biodefense pathogens -- Genomics for biodefense: exploiting the francisella tularensis genome sequence -- Genetic fingerprinting of biodefense pathogens for epidemiology and forensic investigation -- Yersinia pestis as an emerged pathogen: what lessons can be learned? -- Requirements for biological threat identification systems -- DNA-based diagnostic tests for detection and identification of biological weapons -- Concepts for the development of immunodiagnostic assays for detection and diagnosis of biothreat agents.
  • Bioterrorism 2004, CRCnetBASE
  • Anthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
  • Anthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
  • Infectious diseases remain a substantial drain on human well-being and economies despite the availability of modern drugs. New pathogens emerge and known pathogens change their geographical distribution and their susceptibility to the available drugs. An understanding of the structure and function of infectious disease pathogens is a major scientific challenge with important potential applications. This monograph series provides up-to-date information on the latest developments in infectious disease research. The multi-authored volumes cover basic biology and biochemistry of pathogens as well as applied medical aspects and implications for public health and policy.-- Excerpted from publisher notes.
  • The Cytokine System --The Discovery of the Brain Immunomodulators --Brain Neuroendocrine Immune System: Neurosecretion of Interleukins and New Cytokines Produced by NSO and NPV of Hypothalamus --Antibacterial and Antiviral Activity of PRP-1 (Galarmin) and Some Immunological Mechanisms of its Action --Treatment and Prophylaxis of Anthrax by Galarmin: Receptor Tyrosine Kinases is a Target of Galarmin --Prophylaxis and Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection with Proline-Rich Polypeptides Galarmin and Its Structural Analogues in an Experimental Murine Model --Treatment of Clostridium Perfringens-induced Gas Gangrene by New Cytokines of Brain --Hypothalamic, Proline-Rich Polypeptide (Galarmin) has Protective and Immunogenic Activity on Experimental Mycobacterium Tuberculosis Infection --Brain-Bone Marrow Neurohumoral Axis: Galarmin Controls Differentiation, Proliferation and Mobilization of Bone Marrow Progenitor cells --Antioxidant-Antiradical and Electron Donating Function of Galarmin and Gx-NH2 --Discussion --Summary.
  • Executive summary -- Report of the working-group meeting / Christos Louis and Bart G.J. Knols -- Review of previous applications of genetics to vector control / Chris F. Curtis -- Genomics and expected benefits for vector entomology / Christos Louis -- Genetic approaches for malaria control / Marcelo Jacobs-Lorena -- Current thoughts about the integration of field and laboratory sciences in genetic control of disease vectors / Thomas W. Scott -- Genetic approaches in Aedes aegypti for control of dengue: an overview / Kenneth Olson .... [et al.] -- Malaria and dengue vector biology and control in West and Central Africa / Didier Fontenille and Pierre Carnevale -- Malaria and dengue vector biology and control in Southern and Eastern Africa / Maureen Coetzee -- Malaria and dengue vector biology and control in Southeast Asia / Pattamaporn Kittayapong -- Malaria and dengue vector biology and control in Latin America / Mario H. Rodriguez -- Transition from the laboratory to the field and effective interplay / Christos Louis -- Evaluation of drive mechanisms (including transgenes and drivers) in different environmental conditions and genetic backgrounds / Anthony A. James ... [et al.] -- Tools for monitoring the genetic structure and stability of mosquito populations / Gregory C. Lanzaro, Sergey Nuzhdin and Frederic Tripet -- What are relevant assays for refractoriness / George K. Christophides ... [et al.] -- Fitness studies: developing a consensus methodology / Thomas W. Scott ... [et al.] --Mosquito mating behaviour / Willem Takken ... [et al.] -- Pathogen evolution issues in genetically modified mosquito vector strategies / Mario H. Rodriquez -- Models to investigate some issues regarding the feasibility of driving refractoriness genes into mosquito vector populations / Chris F. Curtis -- Identification and characterization of field sites for genetic control of disease vectors / Bart G.J. Knols and Hervé Bossin -- Application of genetically modified mosquitoes in national vector control programmes: thoughts on integrated control / Abraham Mnzava ... [et al.] -- Entomological correlates of epidemiological impacts: how do we know it is working? / Andrew Githeko -- Ethical, legal and social issues in the use of genetically modified vectors for disease control / Yeya T. Touré and Lucien Manga.
  • Basic principles in the diagnosis and management of small animal infection -- Laboratory diagnosis of canine and feline infectious diseases -- Isolation in cell culture -- Immunoassays -- Isolation and identification of aerobic and anaerobic bacteria -- Isolation and identification of fungi -- Nucleic acid detection assays -- Antiinfective therapy -- Principles of antiinfective therapy -- Antiviral and immunomodulatory drugs -- Antibacterial drugs -- Antifungal drugs -- Antiprotozoal drugs -- Basic principles for infection control -- Infection control programs for dogs and cats -- Immunization -- Major infectious diseases and their etiologic agents -- Viral diseases -- Rabies -- Canine parvovirus infections and other viral enteritides -- Canine distemper virus infection -- Canine herpesvirus infection -- Canine viral respiratory infections -- Infectious canine hepatitis -- Feline panleukopenia virus infection and other viral enteritides -- Feline coronavirus infection -- Feline immunodeficiency virus infection -- Feline leukemia virus infection -- Feline respiratory viral infections -- Feline poxvirus infections -- Pseudorabies -- Viral papillomatosis -- Vector-borne and other viral encephalitides -- Bacterial diseases -- Ehrlichiosis -- Anaplasmosis -- Rocky mountain spotted fever -- Salmon poisoning disease -- Coxiellosis and q fever -- Chlamydial infections -- Streptococcal and enterococcal infections -- Staphylococcus infections -- Gram-negative bacterial infections -- Anaerobic bacterial infections -- Bordetellosis -- Cell wall-deficient bacterial infections -- Mycoplasma infections -- Hemoplasma infections -- Actinomycosis -- Nocardiosis -- Mycobacterial infections -- Salmonellosis -- Enteric Escherichia coli infections -- Campylobacteriosis -- Enteric clostridial infections -- Gastric Helicobacter-like infections -- Leptospirosis -- Lyme borreliosis -- Bartonellosis -- Canine brucellosis -- Tetanus and botulism -- Yersinia pestis (plague) and other yersinioses -- Tularemia -- Bite and scratch wound infections -- Fungal and algal diseases -- Dermatophytosis -- Malassezia infections -- Blastomycosis -- Histoplasmosis -- Cryptococcosis -- Coccidioidomycosis -- Sporotrichosis -- Aspergillosis -- Rhinosporidiosis -- Candidiasis -- Miscellaneous fungal diseases -- Pythiosis, lagenidiosis, and zygomycosis -- Protothecosis -- Pneumocystosis -- Protozoal diseases -- Toxoplasmosis -- Neosporosis -- Leishmaniosis -- Babesiosis -- Cytauxzoonosis -- Canine and feline hepatozoonosis -- Trypanosomiasis -- Giardiasis -- Trichomoniasis -- Cryptosporidiosis -- Isosporiasis -- Miscellaneous protozoal diseases -- Infections of selected organ systems -- Pyoderma, otitis externa, and otitis media -- Osteomyelitis, discospondylitis, and infectious arthritis -- Infections of the cardiovascular system -- Bacterial bronchopneumonia and pyothorax -- Intra-abdominal infections -- Bacterial infections of the genitourinary tract -- Bacterial meningitis -- Vaccination schedules for dogs and cats.
  • "This new volume ... aims to address demands and challenges that various infections present to the world at large ('global challenges'), such as the HIV pandemic, continuous threat of spreading common multiresistant pathogenic bacteria, multidrug and extensive drug-resistant tuberculosis, and the influence we can expect on these epidemics with global climate change and international urbanization ... Chapters on these various topics authored by world-renowned experts on these areas provide state-of-the-art reviews on epidemiology, biology, clinical aspects, prevention, current approaches to control, and prevention such as new vaccines, and reassessment of past and present methods are discussed"--Preface.
  • Changing face of disease 2004, CRCnetBASE
    Emerging disease in the third epidemiological transition -- Life history perspectives on human disease -- The Evolution, transmission and geographic spread of infectious diseases in human populations: questions and models -- Genetic epidemiology of parasitic diseases -- Urban pollution, disease and the health of children -- Protecting pregnant women from malaria -- Interdisciplinary research on Schistosoma japonicum -- Unravelling gene-environment interactions in type 2 diabetes -- Investigating the "hidden" epidemic: sexual behaviour and representation of HIV/AIDS amongst business people and medical personnel in five Central and Eastern European nations -- The Evolution of disease and the devolution of health care for American Indians -- The Public's health: the changing role of public health -- Human behaviour and the changing pattern of disease.
  • Chlamydia pneumoniae 2004, Springer
    1. Chlamydia pneumoniae: prospects and predictions for an emerging pathogen / Scot P. Ouellette and Gerald I. Byrne -- 2. Morphology of Chlamydia pneumoniae / Naoyuki Miyashita and Akira Matsumoto -- 3. Cell and molecular biology of Chlamydia pneumoniae / Gunn Christiansen, Brian Vandahl, and Svend Birkelund -- 4. Antibiotic susceptibility and treatment of Chlamydia pneumoniae infections / Margaret R. Hammerschlag -- 5. Pneumonia caused by Chlamydia pneumoniae / Francesco Blasi ... [et al.] -- 6. Chlamydia detection in blood / Yoshimasa Yamamoto -- 7. Chlamydia pneumoniae infection and diseases: imunity to Chlamydia pneumoniae / Heljä-Marja Surcel -- 8. Vaccines against Chlamydia pneumoniae: can they be made? / Martin E. Rottenberg, Antonio Gigliotti Rothfuchs, and Hans Wigzell -- 9. Chlamydia pneumoniae and atherosclerosis - an overview of the Association / Joseph Ngeh and Sandeep Gupta --10. The biology of Chlamydia pneumoniae in cardiovascular disease pathogenesis / Scot P. Ouellette ... [et al.] -- 11. Animal models of Chlamydia pneumoniae infection and atherosclerosis / Ignatius W. Fong -- 12. Antiinfective trials for the treatment of Chlamydia pneumoniae in coronary artery disease / Joseph B. Muhlestein -- 13. Chlamydia pneumoniae and myocarditis / Håkan G. Gnarpe and Judy A. Gnarpe -- 14. Chlamydia pneumoniae as a candidate pathogen in multiple sclerosis / Charles W. Stratton and Subramaniam Sriram -- 15. Chlamydia pneumoniae in the pathogenesis of Alzheimer's disease / Brian J. Balin ... [et al.] -- 16. Chlamydia pneumoniae and inflammatory arthritis / Judith A. Whittum-Hudson, H. Ralph Schumacher, and Alan P. Hudson -- 17. Role of Chlamydia pneumoniae as an inducer of asthma / David L. Hahn -- 18. Respiratory tract infections caused by C. pneumoniae in pediatric patients / Kazunobu Ouchi.
  • Chlamydial infection 2013, Karger
    Epidemiology and prevention and control programs for chlamydia / C.L. Satterwhite, J.M. Douglas, Jr. -- Chlamydia trachomatis pathogenicity and disease / D. Dean -- Chlamydia trachomatis genome structure / T.E. Putman, D.D. Rockey -- Chlamydia trachomatis : molecular testing methods / C.A. Gaydos -- Treatment of chlamydia trachomatis infections / M.R. Hammerschlag -- The Immunologic Response to Urogenital Infection / R.M. Johnson, W. Geisler -- Chlamydia vaccine development / J.U. Igietseme, C.M. Black -- Maternal and infant chlamydia trachomatis infections / I.G.I.J.G. Rours, M.R. Hammerschlag -- Chlamydia trachomatis infection among sexual minorities / D. Singh, J.M. Marrazzo -- Lymphogranuloma venereum : a concise outline of an emerging infection among men who have sex with men / H.J.C. de Vries, S. Morré.
  • Cholera outbreaks 2014, Springer
    The most feared attribute of the human pathogen Vibrio cholerae is its ability to cause outbreaks that spread like wildfire, completely overwhelming public health systems and causing widespread suffering and death. This volume starts with a description of the contrasting patterns of outbreaks caused by the classical and El Tor biotypes of V. cholerae. Subsequent chapters examine cholera outbreaks in detail, including possible sources of infection and molecular epidemiology on three different continents, the emergence of new clones through the bactericidal selection process of lytic cholera phages, the circulation and transmission of clones of the pathogen during outbreaks, and novel approaches to modeling cholera outbreaks. A further contribution deals with the application of the genomic sciences to trace the spread of cholera epidemics and how this information can be used to control cholera outbreaks. The book closes with an analysis of the potential use of killed oral cholera vaccines to stop the spread of cholera outbreaks.
  • Primary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying PIDs.This book aims to increase the clinical awareness and knowledge of practicing clinicians regarding the diagnosis and management of PIDs. In order to achieve this goal, about 90 cases drawn from real life are presented, along with approximately 300 related questions. The selected case reports are the result of the invaluable cooperation of more than 40 scientists in the field of immunodeficiency. They focus both on the presenting features of patients with PIDs and on the required further investigation and management. Although the case scenarios relate to real histories, some modifications have been made for educational purposes. Each of the numbered cases is followed by the questions, their answers, and additional discussion. Each question focuses on a particular aspect of the PID under consideration, and the topics covered include clinical diagnosis, laboratory findings, molecular mechanisms, and therapy.This practical, case-oriented book will be an invaluable source of guidance on the diagnosis and treatment of patients with PIDs and will be relevant for those working in a variety of specialties and subspecialties.
  • CNS infections 2014, Springer
    "This clinically oriented book covers selected infections of the central nervous system which are of considerable current interest. Aspects that are less well documented, such as spinal cord infections, central nervous system infections in patients with cancer, tropical infections, healthcare-associated ventriculitis or meningitis, and immunological problems in the international traveler are also discussed, as these are all problems relevant to daily practice."--Publisher's website.
  • Common cold 2009, Springer
  • Diagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections - epidemiology, immunity, cell biology, virulence factors -- Legionnaires' disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections: adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections: adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
  • Comparative hepatitis 2008, Springer
  • General biology / Ronald Fayer -- Genomics / Jessica C. Kissinger -- Biochemistry / Guan Zhu -- Epidemiology / Gordon Nichols -- Molecular epidemiology / Lihua Xiao and Una M. Ryan -- Diagnostics / Huw Smith -- Immune responses / Vincent McDonald -- Clinical disease and pathology / Cirle Alcantara Warren and -- Richard l. Guerrant -- Prophylaxis and chemotherapy / Heather D. Stockdale, Jennifer A. Spencer, and Byron L. Blagburn -- Foodborne transmission / Ynes R. Ortega and Vitaliano A. Cama -- Waterborne: drinking water / Jennifer L. Clancy and Thomas M. Hargy -- Waterborne: recreational water / Michael Beach -- Waste management / Dwight D. Bowman -- Fish, amphibians and reptiles / Thaddeus Graczyk -- Birds / Una Ryan and Lihua Xiao -- Zoo and wild mammals / Olga Matos -- Companion animals / Mónica Santín and James M. Trout -- Livestock / Mónica Santín and James M. Trout -- Animal models / Saul Tzipori and Giovanni Widmer -- In vitro cultivation / Michael J. Arrowood.
  • Features of enteric infections in Asia -- Molecular epidemiology of vibrio cholerae and campylobacters isolated in Asian countries -- Diarrheal diseases and probiotics -- Dengue and chikungunya virus infection in Southeast Asia: active governmental intervention in Republic of Singapore -- Current global situation of tuberculosis, with a focus on Japan -- Tuberculosis among the poor -- The status and trends of HIV/AIDS epidemics in Asia and the Pacific -- Disease characteristics and treatment of 2009 H1N1 influenza -- Drug-resistant respiratory pathogens in Japan.
  • Subcutaneous and deep mycoses -- Hyalohyphomycosis -- Superficial mycoses -- Algae -- Mycobacteria -- Viruses -- Rickettsiae -- Crusted scabies -- Protozoa -- Helminth -- Spirochete -- Gram-Positive bacteria -- Gram-negative bacteria -- Viral related malignancies -- Clues to the diagnosis of skin lesions in the immunocompromised host -- Differential diagnoses.
  • Introduction -- Specimen Collection and Handling -- Host Reactions to Infection -- Microbiology -- Gynecological Infections -- Pulmonary Infections -- Gastrointestinal and Hepatobiliary Infections -- Urinary Tract Infections -- Central Nervous System Infections -- Hematologic Infections -- Breast, Skin, and Musculoskeletal Infections -- Head and Neck Infections -- Immunosuppressed Host -- Ancillary Investigations -- Mimics and Contaminants.
  • Dengue. New ed. 2009, WHO
    "Since the second edition of Dengue haemorrhagic fever: diagnosis, treatment, prevention and control was published by the World Health Organization (WHO) in 1997, the magnitude of the dengue problem has increased dramatically and has extended geographically to many previously unaffected areas. It was then, and remains today, the most important arthropod-borne viral disease of humans. Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA55.17 (adopted by the Fifty-fifth World Health Assembly in 2002) and at the regional level by resolution CE140.R17 of the Pan American Sanitary Conference (2007), resolution WPR/RC59.R6 of the WHO Regional Committee for the Western Pacific (2008) and resolution SEA/RC61/R5 of the WHO Regional Committee for South-East Asia (2008). This new edition has been produced to make widely available to health practitioners, laboratory personnel, those involved in vector control and other public health officials, a concise source of information of worldwide relevance on dengue. The guidelines provide updated practical information on the clinical management and delivery of clinical services; vector management and delivery of vector control services; laboratory diagnosis and diagnostic tests; and surveillance, emergency preparedness and response. Looking ahead, some indications of new and promising avenues of research are also described. Additional and more detailed specific guidance on the various specialist areas related to dengue are available from other sources in WHO and elsewhere, some of which are cited in the references. The contributions of, and review by, many experts both within and outside WHO have facilitated the preparation of this publication through consultative and peer review processes. All contributors are gratefully acknowledged, a list of whom appears under "Acknowledgements". These guidelines are the result of collaboration between the WHO Department of Control Neglected Tropical Diseases, the WHO Department of Epidemic and Pandemic Alert and Response, and the Special Programme for Research and Training in Tropical Diseases. This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity, since many aspects of the prevention and control of dengue are currently being investigated in a variety of studies. The guidelines contain the most up-to-date information at the time of writing. However, the results of studies are being published regularly and should be taken into account. To address this challenge, the guide is also available on the Internet and will be updated regularly by WHO." - p. v.
  • Part I. Approach to patients. Approach to patients with suspected fungal infections / Clinton K. Murray and Duane R. Hospenthal -- Part II. Laboratory and radiological diagnosis. Basic mycology / Deanna A. Sutton -- Diagnostic histopathology / Michael B. Smith and Michael R. McGinnis -- Diagnostic immunology / Samit S. Desai and Brian Wong -- Diagnostic radiology / Maria Angela C. Hospenthal and Constanza J. Gutierrez -- Part III. Antifungal agents. Antifungal agents / Russel E. Lewis and Annette W. Fothergill -- Part IV. Mycoses. Cadidiasis / Jack D. Sobel -- Infection due to non-candidal yeasts /Jose A. Vazquez -- Aspergillosis / Helen W. Boucher and Thomas F. Patterson -- Hyalophomycosis infection due to hyaline moulds / Rhonda V. Fleming and Elias J. Anaissie -- Phaeohyphomycosis infection due to dark (dematiaceous) moulds / Sanjay G. Revankar -- Zygomycosis (mucormycosis) / Charalampos Antachopoulos, Juan C. Gea-Banacloche, and Thomas J. Walsh -- Pneumocystosis / Francis Gigliotti and Terry W. Wright -- Cryptococcosis / Mathee Chayakulkeeree and John R. Perfect -- Blastomycosis / Stanley W. Champan and Donna C. Sullivan -- Coccidioidomycosis / Royce H. Johnson and Chehla Baqi -- Histoplasmosis / L. Joseph Wheat and Nicholas G. Conger -- Paraccocidiodoycosis / Angela Restrepo, Angela M. Tobón, and Carlos A. Agudelo -- Sporotrichosis / Carol A. Kauffman -- Dermatophytosis (tinea) and other superficial fungal infections / Aditya K. Gupta and Elizabeth A. Cooper -- Subcutaneous fungal infections (chromoblastomycossi, mycetoma, and lobomycosis) / Michael B. Smith and Michael R. McGinnis
  • Perspectives on infection challenges and solutions / Manivannan -- Sisyphus in the microbial world revisited : global governance, antimicrobial strategies, and humanity's health / Fidler -- The need for safer and better microbiocides for infection control / Sattar, Springthorpe -- Microbiological concerns in non-sterile manufacturing / Farrington, Polarine -- New technologies in disinfection and infection control / Ramirez -- Biocides : modes of action and mechanisms of resistance / McDonnell -- A pragmatic approach to judicious selection and proper use of disinfectant and antiseptic agents in healthcare setting / Suljagic -- Extended activity of healthcare antiseptic products / Newman, Kaiser -- Disinfectant rotation in a cleaning/disinfection program for cleanrooms and controlled environments / Sutton -- Reprocessing flexible endoscopes : origin of standards, overview of structure/function, and review of recent outbreaks / Antonucci, Williams, Robinson -- Microbiological testing of disinfectants and decontaminants for critical surfaces / Klein -- Regulatory constraints on disinfectants and decontamination / Sarli -- Biofilms : a summarized account and control strategies / Nandakumar, Sreekumari -- Consequences of biofilms on indwelling medical devices : costs and prevention / Thomas, Nakaishi, Corum -- Infection-resistant implantable devices : biofilm problems and design strategies / Smith, Perera -- Infections of intracardiac devices / Yesenosky ... [et al.] -- Intrauterine devices : infections and biofilms / Pereira, Pruthi -- Antimicrobial urinary catheters / Stickler, Sabbuba -- Risk factors for post-operative infectious complications after abdominal surgery / Pessaux, Lermite.
  • Introduction to Drug-Drug Interactions -- Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion -- Mechanisms of Drug Interactions II: Transport Proteins -- Drug-Food Interactions -- Interactions Between Herbs and Antiinfective Medications -- Drug-Cytokine Interactions -- Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions with Antiretrovirals for HIV Infection -- Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelmintic Agents -- Drug Interaction Considerations Throughout Drug Development -- Probe Cocktail Studies -- Design and Data Analysis in Drug Interaction Studies.
  • The why and how of dynamic modeling -- Basic epidemic models -- Insect dynamics -- Malaria and sickle cell anemia -- Encephalitis -- Chagas disease -- Lyme disease -- Chicken pox and shingles -- Toxoplasmosis -- The zebra mussel -- Biological control of pestilence -- Indirect susceptible-infected-resistant models of arboviral encephalitis transmission -- Chaos and pestilence -- Catastrophe and pestilence -- Spatial pestilence dynamics.
  • This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics.
  • Chapter 1. Identifying general requirements -- Chapter 2. Identifying detailed requirements -- Chapter 3. Selecting a solution -- Chapter 4. Implementing an electronic recording and reporting system .
  • Global effects and prevention of emerging and epidemic pathogens: cholera and citrus greening as examples -- Surveillance -- Epidemiological surveillance of highly pathogenic diseases in Kazakhstan -- Surveillance on plague in Natural foci in Georgia -- Application of modern techniques for studying bacterial pathogens in Georgia -- Especially dangerous infections in Azerbaijan -- Strengthening the early-warning function of the surveillance system: the Macedonian experience -- Integrating geographic information systems and ecological niche modeling into disease ecology: a case study of Bacillus anthracis in the United States and Mexico -- Molecular analysis and tools -- Applications of paleomicrobiology to the understanding of emerging and re-emerging infectious diseases -- Characterization of a putative hemagglutinin gene in the caprine model for brucellosis -- Pathoadaptation of especially dangerous pathogens -- Detection of pathogens via high-throughput sequencing -- Environmental infuences on the relative stability of baculoviruses and Vaccinia virus: a review.
  • Emerging epidemics 2013, Wiley
    A global perspective on the management and prevention of emerging and re-emerging diseases Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse. This book takes a look at the worl
  • pt. 1. Identifying emerging pathogens -- pt. 2. Individual pathogens.
  • The Singapore contribution in the battle against the severe acute respiratory syndrome / Fielding, B.C., Tan, Y.-J. -- Avian influenza in Thailand / Puthavathana, P. ... [et al.] -- Emerging viral diseases of fish and shrimp / Wang, M. ... [et al.] -- Avian influenza H5N1 virus: an emerging global pandemic / Lal, S.K., Chow, V.T.K. -- Henipaviruses: new threats for Southeast Asia and Australia / McCormack, J., Smith, G. -- Ross River virus: an arthritogenic alphavirus of significant importance in the Asia Pacific / Tupanceska, D. ... [et al.] -- Emerging and re-emerging infectious diseases in our global village / Heymann, D.L. -- Role of a pathology laboratory in SARS and other emerging infections / Nicholls, J., Peiris, J.S.M. -- The fight against emerging viral diseases in Asia / Lam, S.K.
  • "'Do no harm' a particularly leading and important phrase in the delivery of healthcare is not working. In fact depending on the epidemiological approach and which data sets one applies, medical errors, hospital acquired infections (HAIs) and pharmaceutical errors combined are the second or third leading killer of Americans annually: approximately 300,000 die from a combination of medical errors, hospital acquired infections (HAIs), and pharmaceutical errors...100,000 per category. Add to these numbers the hundreds of thousands who are harmed (morbidity) but not killed (mortality) changing quality of life and a substantial problem is defined"--Provided by publisher.
  • Epidemiological odyssey 2012, Springer
    1.Early Concepts of Communicability --2.Infection on the Move --3.The Impact of Cholera --4.Stiffening the Sinews --5.Dawn and Sunset --6.A Need for Damage Limitation --7.No Lasting Stability --8.Tailpiece.
  • Part I. Upper Respiratory Tract Infections -- 1. Clinical guidelines: community acquired pneumonia / John Russell -- 2. Pharyngitis / Adrian Wilson -- 3. Treatment and management of acute otitis media / Ross H. Albert and Neil S. Skolnik -- 4. Management of chronic obstructive pulmonary disease exacerbations and acute bronchitis / Michael Gagnon -- 5. Latent tuberculosis infection: testing and treatment / Pamela Ann Fenstemacher -- 6. Sinusitis / Megan Werner and Mathew Clark -- Part II. Gastrointestinal Infections -- 7. Gastroenteritis / Andrew Deroo and Matthew Mintz -- 8. Hepatitis / Michele Lamoreux -- III. Sexually Transmitted Diseases -- 9. Sexually transmitted diseases / Neil Skolnik -- 10. Human immunodeficiency virus / Rosemary Harris -- IV. Skin, Bone, and Joint Infection -- 11. Cellulitis and skin infections associated with bites / Steven Zinn and Judith O'Donnell -- 12. Diabetic foot infections / Thomas C. McGinley Jr. -- 13, Osteomyelitis / Kelly Gannon and Todd Braun -- 14. Septic arthritis and infectious bursitis / Gene Hong and Nirandra Mahamitra -- 15. Lyme disease prevention, diagnosis, and treatment / Ross Albert and Neil Skolnik -- V. Other Infectious Disease Topics -- 16. Infective endocarditis / Tina Degnan and Neil Skolnik -- 17. Meningitis / Anne T. Wiedemann -- 18. Urinary tract infections / Jennifer Neria and Matthew Mintz -- 19. Adult immunizations / John Russell and Ross Albert -- 20. Clinical ethics and infectious disease in family medicine / Janet Fleetwood.
  • How to search for evidence -- Epidemiology -- Clinical manifestations -- Laboratory tests -- Rational antibiotic use -- Adjunctive treatment -- Bacterial meningitis -- Respiratory tract infections -- Osteomyelitis and septic arthritis -- Urinary tract infections -- Necrotizing enterocolitis and gastrointestinal infections -- Eye infections -- Skin and soft tissue infections -- Bacterial infections -- Mycoplasmas -- Fungal infections -- Viral infections -- Other congenital infections -- Breast milk -- Surveillance -- Infection control -- Developing countries -- Prevention of neonatal infections -- Neonatal antimicrobials.
  • "These guidelines have been written for public health practitioners, food and health inspectors, district and national medical officers, laboratory personnel and others who may undertake or participate in the investigation and control of foodborne disease outbreaks."--P. 4 of cover.
  • Foodborne pathogens 2002, CRCnetBASE
  • Foot and mouth disease 2003, Wellcome Trust
  • This SpringerBrief on Spx reviews the investigations that led to the discovery of Spx and its orthologs and ties together the results of various studies that have explored the function and control of spx in Gram-positive organisms. Spx of Bacillus subtilis has been extensively studied, but very little has been published about it. This book incorporates a number of studies that have been conducted in other Gram positive bacteria, which examined the role of Spx orthologs in stress response, bacterial development and virulence. The book contains an overview that will introduce the protein and its orthologous forms, its association with RNA polymerase, the species of Gram-positive bacteria in which it is found, and the conditions in which it is abundant and active. Spx is a member of a large group of proteins belonging to the ArsC/Spx protein family, so the review touches upon the bioinformatic support for the protein family composition and its meaning with regard to protein structure/function.
  • Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in making predictions under new or changing pre-clinical and clinical circumstances. Not surprisingly, pharmacokinetic-pharmacodynamic modeling concepts are increasingly applied in both basic and clinical research as well as in drug development. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics is designed as a reference on the application of pharmacokinetic-pharmacodynamic principles for the optimization of antimicrobial therapy, namely pharmacotherapy, and infectious diseases. The reader is introduced to various aspects of the fundamentals of antimicrobial pharmacodynamics, the integration of pharmacokinetics with pharmacodynamics for all major classes of antibiotics, from basic research to clinical situations.
  • "This fourth volume of the Global Burden of Disease and Injuries Series provides the reader with information on the epidemiology and burden of major infectious and parasitic diseases. As with previous volumes of the Global Burden of Disease study, the chapters in this book detail the situation as experienced in the year 1990. Since then the epidemiology of some of the conditions described has changed, and where this is the case the authors have added a brief paragraph acknowledging this. The chapters therefore do not provide a detailed update on the current burden of disease, which is accommodated in the documentation of the Global Burden of Disease 2000 and published elsewhere."--Preface.
  • "Using the two-page, templated organization of the 5-Minute Consult series, Gorbach's 5-Minute Infectious Diseases Consult, Second Edition provides comprehensive coverage for clinicians dealing with infectious diseases. The two major sections of the book cover chief complaints and individual diseases and disorders. Additional materials include summary information about individual microorganisms as well as numerous elements related to drugs for infectious disorders. A team of international authorities provides actionable information, supported by current research and practice guidelines.Features Include: Comprehensive coverage of infectious diseases, important symptoms, microorganisms, and anti-infective drugs Coverage of emerging infectious diseases such as H1N1 flu Increased coverage of tropical diseases Two-page, tightly written chapters Updated information about management of HIV/AIDS "--Provided by publisher.
  • "Preface Almost 1,800 media are described in the Handbook of Media for Clinical and Public Health Microbiology, including newly described media for the cultivation of emerging pathogens. Diseases caused by emerging pathogens that are responsible for increased rates of morbidity and mortality rates, such as Escherichia coli O157:H7, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant enterococci (VRE), and carbapenem resistant enterococci (CRE) have raised special concerns and various media included in the Handbook have been designed for the specific cultivation and identification of these pathogens. Many of the new media included in the Handbook of Media for Clinical and Public Health Microbiology permit the cultivation of bacteria, fungi, and viruses that are currently causing major medical problems around the world. These media are very important for the rapid detection of pathogenic microorganisms and the diagnosis of individuals with specific infectious diseases adn for preventing the spread of pathogens via food, water, and environmental sources. Several of the new media described in the Handbook of Media for Clinical and Public Health Microbiology include chromogenic or fluorogenic substrates that permit the rapid detection of specific pathogens. An important function of the Handbook of Media for Clinical and Public Health Microbiology is to provide descriptions of the media that are used to cultivate and identify microorganisms from clinical specimens and those of public health significance. The Handbook provides a compilation of the formulations, methods of preparation, and applications for media used in clinical and public health microbiology laboratories"--Provided by publisher.
  • Hepatitis C virus infection and the role of the immune system -- Cryoglobulinemia: immunochemical characterization, serological abnormalities and histopathological changes -- Structural and genetic features, cytokines and chemokines in cryoglobulinemia -- Cellular compartments of HCV infection (and replication) -- Mechanism(s) of cryoprecipitation -- Clinical manifestations of cryoglobulinemia -- HCV infection, cryoglobulinemia and non-Hodgkin's lymphomas -- Therapy of cryoglobulinemia.
  • Updated information on stem cells for the neonatologist -- Current issues in the pathogenesis, diagnosis, and treatment of neonatal thrombocytropenia -- Role of recombinant leukocyte colony-stimulating factors in the neonatal intensive care unit -- Nonhematopoietic effects of erythropoietin -- Why, when, and how should we provide red cell transfusions and erythropoiesis-stimulating agents to support red cell mass in neonates? -- Diagnosis and treatment of immune-mediated and non-immune-mediated hemolytic disease of the newborn -- Hematology and immunology: coagulation disorders -- A practical approach to the neutropenic neonate -- What evidence supports dietary interventions to prevent infant food hypersensitivity and allergy? -- Maternally mediated nenonatal autoimmunity -- CMV: diagnosis, treatment, and considerations on vaccine-mediated prevention -- Neonatal T cell immunity and its regulation by innate immunity and dendritic cells -- Breast milk and viral infection -- Probiotics for the prevention of necrotizing enterocolitis in preterm neonates -- The ureplasma conundrum: should we look or ignore? -- Control of antibiotic-resistant bacteria in the neonatal intensive care unit -- Neonatal fungal infections -- The use of biomarkers for detection of early-and late-onset neonatal sepsis -- Chorioamnionitis and its effects on the fetus/neonate: emerging issues and controversies.
  • Herpes zoster 2006, karger
    Molecular biology of varicella-zoster virus / Rahaus, M., Desloges, N., Wolff, M.H -- Latency and reactivation of VZV / Lungu, O., Gershon, A.A. -- Laboratory confirmation of herpes zoster / Ludwig, B., Buxbaum, S., Doerr, H.W. -- Clinical picture and complications of herpes zoster: the view of the dermatologist / Gross, G. -- Ophthalmic manifestations of herpes zoster infection / Guembel, H. -- (Herpes) zoster oticus / Pau, H.W. -- Neuroanatomy of pain and neuropathology of herpes zoster and postherpetic neuralgia / Wree, A., Usunoff, K.G. -- Postherpetic neuralgia and other neurologic complications / Baron, R. -- Varicella-zoster virus infections during pregnancy / Sauerbrei, A., Wutzler, P. -- Herpes zoster in the immunocompromised host / Schöfer, H. -- Chickenpox and zoster in marrow transplant recipients / Genvresse, I., Maschmeyer, G. -- General aspects of therapy / Gross, G. -- Antiviral therapy of shingles in dermatology / Lilie, H.M., Wassilew, S.W. -- Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d] pyrimidine nucleoside analogues (BCNAS) / Clercq, E.D. -- Therapy of zoster pain, postherpetic neuralgia and other neurological complications / Baron, R. -- Epidemiology of herpes zoster: what has changed? / Allwinn, R., Buxbaum, S., Doerr, H.W. -- Live attenuated varicella vaccine / Gershon, A.A.
  • Section I. Applied epidemiology and biostatistics in healthcare epidemiology and infection control -- Section II. Healthcare quality improvement -- Section III. Informatics in healthcare epidemiology -- Section IV. Epidemiology and prevention of healthcare-associated infections of organ systems -- Section V. Epidemiology and prevention of healthcare-associated infections caused by specific pathogens -- Section VI. Epidemiology and prevention of healthcare-associated infections in pediatric patients -- Section VII. Epidemiology and prevention of healthcare-associated infections in special patient populations -- Section VIII. Epidemiology and prevention of healthcare-associated infections related to diagnostic and therapeutic procedures -- Section IX. Prevention of healthcare-associated infections related to the hospital environment -- Section X. Epidemiology and prevention of healthcare-associated infections in healthcare workers -- Section XI. Disinfection and sterilization -- Section XII. Prevention of infectsions acquired by patients in healthcare facilities related to design, construction, renovation, demolition and ventilation systems -- Section XIII. Antimicrobial agents in healthcare epidemiology and infection control -- Section XIV. Literature in healthcare epidemiology and infection control -- Section XV. Organization and implementation of infection control programs -- Section XVI. Healthcare epidemiology and infection control in special settings for healthcare delivery -- Section XVII. Bioterrorism.
  • The art of medicine becomes science when supported by evidence. The recommended practices of infection prevention are based on scientific and epidemiologic evidence. However,most health care professionals see them as mandates and fail to incorporate them into their routine patient care activities. Thecore goal of this publication is to link the practices to theprinciples they are based on. The expectation is that understanding ofthe principles willchange thepractices from mandates to "should do" in the minds of health care professionals. This will lead to improvement inhealth care by preventing unintended harm to patients, co-workers and the communities at large. At the same time, the text provides a comprehensive, thorough and up to date information on all aspects of infection prevention in a reader-friendly manner and therefore, will serve as a valuable reference.
  • Development of the First AIDS Drugs: AZT and Other Dideoxynueosides /Robert Yarchoan, Hiroaki Mitsuya --Part I:Structure and Function of HIV RT.Proviral DNA Synthesis in HIV: Background /Dorota Piekna-Przybylska Ph.D., Robert A. Bambara Ph.D. --The RNase H Domain: Structure, Function and Mechanism /Marcin Nowotny, Małgorzata Figiel --Conformational Dynamics of Reverse Transcription /Stuart F. J. LeGrice --Part II:Mechanism of Action of Approved RT Inhibitors.Nucleoside RT Inhibitors: Structural and Molecular Biology /Gaofei Lu, Antonio J. Acosta-Hoyos, Walter A. Scott --Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) /Kalyan Das Ph.D., Eddy Arnold Ph.D., Stephen H. Hughes Ph.D. --Part III:Alternative Strategies to Interfere with the Function of HIV RT.Ribonuclease H Inhibitors: Structural and Molecular Biology /Jason W. Rausch --Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface /Daouda Abba Moussa, Audrey Agopian, Gilles Divita --Targeting RT Translocation /Gregory L. Beilhartz, Brian J. Scarth, Matthias Götte --tRNA Primer Sequestration as an Antiviral Strategy /Christopher P. Jones, Karin Musier-Forsyth --Part IV:HIV Genetic Variability and the Problem of Drug Resistance.HIV Reverse Transcriptase Fidelity, Clade Diversity, and Acquisition of Drug Resistance /Luis Menéndez-Arias --APOBECs and Their Role in Proviral DNA Synthesis /John S. Albin, Reuben S. Harris --Role of RNase H Activity in NRTI/NNRTI Drug Resistance /Gilda Tachedjian B.Sc. (Hons), Ph.D., Nicolas Sluis-Cremer B.Sc. (Hons), Ph.D. --HIV Population Dynamics /Mary Kearney, John Coffin --Part V:Prevention and Future Approaches.RT Inhibitors as Microbicides /Jan Balzarini.
  • Human papillomavirus 2009, Springer
  • Human papillomavirus 2014, Karger
    "Human papillomavirus (HPV) infection transcends multiple fields of science and medicine. The management of HPV-related disease is demanding and often requires a persistent multimodal approach involving various medical disciplines. In this volume, experts present a comprehensive view of HPV research with an emphasis on clinical presentations, diagnosis, management and vaccine development. The state of the art in molecular biology is provided in addition to discussions on clinical morphology and the utility of dermatoscopy in identifying HPV disease. In a multidisciplinary approach to dermatological, plastic and reconstructive, gynecological, otolaryngological and colorectal management, different treatment strategies are highlighted"--Publisher's description.
  • The dissection of CD8 T cells during liver-stage infection / U. Krzych and R.J. Schwenk -- Early interactions between blood-stage Plasmodium parasites and the immune system / B.C. Urban, R. Ing, and M.M. Stevenson -- Longevity of the immune response and memory to blood-stage malaria infection / A.H. Achtman ... [et al.] -- Experimental models of cerebral malaria / C. Engwerda ... [et al.] -- Glycosylphosphatidylinositols in malaria pathogenesis and immunity : potential for therapeutic inhibition and vaccination / C.S. Boutlis ... [et al.] -- The immunology and pathogenesis of malaria during pregnancy / J.G. Beeson and P.E. Duffy.
  • Immunosenescence 2012, Springer
  • In the blink of an eye 2013, Springer
    1. Origins -- 2. The Art and Science of Germs -- 3. A Singular Disease -- 4. A Very Mortal Disease -- 5. Early Approaches at Therapy -- 6. Antibiotics and Survival of the Fittest -- 7. A Brief History of Vaccines -- 8. That Soluble Specific Substance -- 9. Towards a Vaccine -- 10. Success for Half -- 11. The Future of a Killer.
  • The Eye as a model for immune privilege -- Immune privilege of the testis: meaning, mechanisms, and manifestations -- The Role of intrauterine immune privilege in perinatal infectious diseases -- The Liver as an immune-privileged site -- Immune homeostasis of the lung: the role of regulatory NKT cells in asthma -- Immune homeostasis of the gut.
  • Infections in critically ill patients are more common than in most other parts of the hospital, and are often the most complicated to manage. Underlying disease and the reasons for admission make the diagnosis, management and prevention of infection challenging. Developments in technology, the treatment of previously untreatable malignancies, complex surgery procedures, and an increasing age profile result in more patients vulnerable to infection and a greater number of patients needing critical care support. Infections in the Adult Intensive Care Unit is designed to help trainee and practicising physician, surgeon or other medical professional manage the acutely ill patient in the critical care unit, before transfer from the emergency department, or on the hospital ward where effective management may avoid admission to the critical care unit. It has been co-authored by a clinical microbiologist, intensivist and clinical infectious diseases physician to cover some of the major infections presenting in the adult critical care unit. It provides broad principles to be used based on the latest evidence combined with common sense and the results of many years of combined experience.
  • While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results from a complex interplay between the host's underlying immunodeficiencies, local tumor effects, and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones. The aim of this book, is to emphasize unique aspects of management of infectious diseases in the cancer patient. With the increasing complexity of this patient population, optimal management requires a multidisciplinary approach, and this fact is fully reflected in the contributions, all from recognized authorities in the field. Ultimately, it is hoped that this volume will assist specialists in infectious diseases and haematology/oncology in the diagnosis, management, and prevention of infection and optimization of the overall care of patients with malignancies.
  • Concepts and principles of infections and aging -- Epidemiology of aging and infectious diseases -- Factors predisposing to infection -- Clinical features of infection -- Role and importance of functional assessment in infections -- Principles of antimicrobial therapy -- Common infections -- Sepsis -- Bronchitis and pneumonia -- Tuberculosis in older adults -- Infective endocarditis -- Intra-abdominal infections -- Infectious diarrhea -- Urinary tract infection -- Bacterial meningitis and brain abscess -- Osteomyelitis and septic arthritis -- Skin and soft tissues infections -- Herpes zoster -- Orofacial and odontogenic infections in the elderly -- Ocular infections -- Otitis externa, otitis media, and sinusitis -- Prosthetic joint infections in elderly patients -- Staphylococcal and enterococcal infections -- Fungal infections -- Viral infections -- Unique infectious disease problems -- Infections in the long-term care setting -- Infection control programs in nursing homes -- Infections in diabetes -- Vaccinations -- Nutrition and infection -- Sexually transmitted diseases -- Human immunodeficiency virus/acquired immunodeficiency syndrome -- SARS and West Nile virus.
  • Informatics for infectious disease research and control -- Bioinformatics of microbial sequences -- Mining databases for microbial gene sequences -- Comparative genomics of pathogens -- Systems microbiology: gaining insights in transcriptional networks -- Host-pathogen systems biology -- Text mining for discovery of host-pathogen interactions -- Network approach to understanding pathogen population structure -- Computational epitope mapping -- Pangenomic reverse vaccinology -- Immunoinformatics: the next step in vaccine design -- Understanding the shared bacterial genome -- Computational grammars for interrogation of genomes -- In silico discovery of chemotherapeutic agents -- Informatics for healthcare epidemiology -- Automated, high-throughput surveillance systems for public health -- Microbial genotyping systems for infection control -- Temporal and spatial clustering of bacterial genotypes -- Infectious disease ontology -- Populations, patients, germs and genes: ethics of genomics and informatics in communicable disease control.
  • This fully updated edition of Infectious Disease Surveillance is for frontline public health practitioners, epidemiologists, and clinical microbiologists who are engaged in communicable disease control. It is also a foundational text for trainees in public health, applied epidemiology, postgraduate medicine and nursing programs. The second edition portrays both the conceptual framework and practical aspects of infectious disease surveillance. It is a comprehensive resource designed to improve the tracking of infectious diseases and to serve as a starting point in the developme.
  • Infectious diseases 2013, Springer
    Infectious Diseases: Selected Entries from the Encyclopedia of Sustainability Science and Technology presents authoritative, peer-reviewed contributions from leading experts on a wide range of major infectious diseases of global importance. Infectious diseases account for more than 17 million deaths each year worldwide. While modern medicine and technology have diminished the threat of many of these pathogens in high-income countries, the ever present threats of re-emerging infections, population mobility, natural disasters, and pathogen genetic variability are but some of the reasons for the dynamic threat of this broad category of risks to human health. An indispensable resource for students and scientists, the volume also covers some of the new technologies currently under development for infectious disease prevention, treatment, and eradication. The greater part of the infectious disease burden remains in the tropics, where low and middle-income countries lack the resources, infrastructure, and health systems to mount or sustain control efforts. Many contributions describe the efforts of the scientific research community and international donor agencies to achieve the integrated goals of vigilant surveillance, improved and cost-effective diagnostics, and treatment for sustainable disease control.Describes the dynamic nature of infectious disease agents and their complex interactions with the environment and their human and animal hosts Covers new technologies for antibiotics, vaccines, and treatment Features several contributions on waterborne infectious diseases, including enteric viruses and bacterial pathogens in the ocean Provides an excellent introduction for those entering the field, as well as new insights for advanced researchers and industry experts
  • v. 2 Springer
    The volumes address the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences.
  • "THE INFECTIOUS DISEASES OF HAITI is one in a series of GIDEON e-books which summarize the status of individual infectious diseases, in every country of the world. Data are based on the GIDEON database (www.gideononline.com) which relies on standard text books, peer-review journals, Health Ministry reports and ProMED, supplemented by an ongoing search of the medical literature. Chapters are arranged alphabetically, by disease name. Each section is divided into four sections: 1. Descriptive epidemiology; 2. Summary of clinical features; 3. Status of the disease in Haiti ; 4. References. The initial items in the first section, Descriptive epidemiology, are defined as follows: Agent: Classification (e.g., virus, parasite) and taxonomic designation; Reservoir: Any animal, arthropod, plant, soil or substance in which an infectious agent normally lives and multiplies, on which it depends primarily for survival, and where it reproduces itself in such a manner that it can be transmitted to a susceptible host; Vector: An arthropod or other living carrier which transports an infectious agent from an infected organism or reservoir to a susceptible individual or immediate surroundings; Vehicle: The mode of transmission for an infectious agent. This generally implies a passive and inanimate (i.e., non-vector) mode. There are 347 generic infectious diseases in the world today. 198 of these are endemic, or potentially endemic, to Haiti. A number of other diseases are not relevant to Haiti and have not been included in this book. In addition to endemic diseases, we have included all published data regarding imported diseases and infection among expatriates from this country. The availability and quality of literature regarding specific infectious diseases varies from country to country. As such, you may find that many of the sections in this book are limited to a general discussion of the disease itself - with no data regarding the country under review. Since this book focuses on Geographic Medicine, it does not include detailed information on diagnostic testing, pathogenesis, therapy or molecular biology. Many of the diseases are generic. For example, such designations as Pneumonia bacterial and Urinary tract infection include a number of individual diseases. These appear under the subheading, Synonyms, listed under each disease. The entire book will be updated on a regular basis.
  • Print Material
  • pt. 1. Evolution and epidemiology -- pt. 2. Immunity and vaccine strategies -- pt. 3. Economic and social implications.
  • Influenza. 1st ed. 2002, ScienceDirect
  • "The purpose and scope of the International Health Regulations (2005) are "to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade". Because the IHR (2005) are not limited to specific diseases but apply to new and ever-changing public health risks, they are intended to have long-lasting relevance in the international response to the emergence and spread of disease. The IHR (2005) also provide the legal basis for important health documents applicable to international travel and transport and sanitary protections for the users of international airports, ports, and ground crossings. This second edition contains the text of the IHR (2005), the text of World Health Assembly resolution WHA58.3, the version of the Health Part of the Aircraft General Declaration that entered into force on 15 July 2007, appendices containing a list of States Parties and State Party reservations and other communications in connection with the IHR (2005)."-- back cover.
  • "While the public health philosophy of the 20th Century -- emphasizing prevention -- is ideal for addressing natural disease outbreaks, it is not sufficient to confront 21st Century threats where adversaries may use biological weapons agents as part of a long-term campaign of aggression and terror. Health care providers and public health officers are among our first lines of defense. Therefore, we are building on the progress of the past three years to further improve the preparedness of our public health and medical systems to address current and future BW [biological warfare] threats and to respond with greater speed and flexibility to multiple or repetitive attacks." Homeland Security Presidential Directive 21 Bioterrorism is not a new threat in the 21st century -- thousands of years ago the plague and other contagious diseases were used in warfare -- but today the potential for catastrophic outcomes is greater than it has ever been. To address this threat, the medical and public health communities are putting various measures in place, including systems designed to pro-actively mon- itor populations for possible disease outbreaks"--Provided by publisher.
  • Iron Acquisition by the Genus Mycobacterium summarizes the early evidence for the necessity of iron in mycobacteria and the discovery of the mycobacterial siderophores mycobactin, carboxymycobactin, and exochelin. The structural characterization of the mycobacterial siderophores is described. The genes so far identified as essential for iron acquisition and maintenance of an infection by pathogenic mycobacteria are discussed. The potential role of siderocalin in iron gathering by M. tuberculosis is featured. Because new drugs for M. tuberculosis are needed, this brief also emphasizes the design of antibiotics that interfere with siderophore biosynthesis and the use of siderophore analogs and/or conjugates.
  • Print Material
  • Part 1.GENERAL SECTION /History and Phylogeography of Leprosy /Stewart T. Cole and Pushpendra Singh --Microbiology /Andrea Clapasson and Silvia Canata --Genetics of Leprosy /Vinicius Medeiros Fava and Marcelo Távora Mira --Host Response to M. leprae /Rodrigo Ribeiro-Rodrigues --Pathogenesis /Cesare Massone and Enrico Nunzi --Classification /Cesare Massone and Alexandra M. G. Brunasso --Part 2.PATIENT'S EXAMINATION --Patient History /Enrico Nunzi, Cesare Massone and Salvatore Noto --Laboratory Investigations /Andrea Clapasson and Silvia Canata --Part 3.SKIN --Physical Examination: Skin /Enrico Nunzi, Cesare Massone and Salvatore Noto --Clinical Features /Enrico Nunzi, Cesare Massone and Salvatore Noto --Lucio-Latapí Leprosy /Mario Magaña --Histopathology of the Skin /Cesare Massone --Differential Diagnosis: Skin /Enrico Nunzi and Salvatore Noto --Part 4.NERVES --Peripheral Nerves in Leprosy /Bernard Naafs and José Antônio Garbino --The Leprosy Neuropathy /Lizia Reni, Salvatore Noto and Pieter A. M. Schreuder --Primary Neural Leprosy /José Antônio Garbino and Bernard Naafs --Chronic Neuropathic Pain in Leprosy /José Antônio Garbino, Bernard Naafs and Pedro Schestatsky --Electrodiagnostic Studies /Lizia Reni --Imaging /Carlo Martinoli, Leila Oppezzi and Alberto Tagliafico --Differential Diagnosis: Nerves /Lizia Reni --Part 5.Reactions in Leprosy /Reactions in Leprosy /Bernard Naafs and Salvatore Noto --Lucio's Phenomenon /Mario Magaña --Part 6.SYSTEMIC INVOLVEMENT --Ocular Involvement in Leprosy /Susan Lewallen and Paul Courtright --Otolaryngological Manifestations of Leprosy /Sinésio Talhari, Camila Bandeira de Oliveira and Carolina Talhari --Other Organs /Enrico Nunzi and Salvatore Noto --Part 7.PATIENT'S MANAGEMENT --Diagnostic Work-Up /Enrico Nunzi, Cesare Massone and Salvatore Noto --Drugs in Leprosy /Sinésio Talhari and Mahreen Ameen --Treatment and Prophylaxis /Pierre Bobin --Prognosis /Enrico Nunzi --Neurolysis /Sergio S. G. Gennaro --Prevention of Disability and Ulcer Care /J. Wim Brandsma and Hugh Cross --Surgical and Social Rehabilitation /J. Wim Brandsma and Sunil Deepak --Part 8.LEPROSY AND COMMUNITY --Leprosy in Pregnancy /Elizabeth Duncan --Leprosy and HIV/AIDS Co-infection /Sinésio Talhari and Carolina Talhari --Epidemiology of Leprosy /Salvatore Noto and Pieter A. M. Schreuder --Leprosy Control /Sunil Deepak and Giovanni Gazzoli --Teledermatology /Cesare Massone and Antonio Pedro Mendes Schettini --The Leprosy Mailing List /Salvatore Noto.
  • Malaria 2005, Springer
  • Management of sepsis 2009, Springer
  • Print Material
    Vol. 1. -- Part I - Basic principles in the diagnosis and management of infectious diseases -- Microbial virulence factors -- Host defense mechanisms -- Epidemiology of infectious diseases -- Clinical microbiology -- Anti-infective therapy -- Part II - Major clinical syndromes -- Fever -- Upper respiratory tract infections -- Pleuropulmonary and bronchial infections -- Urinary tract infection -- Sepsis -- Intra-abdominal infection -- Cardiovascular infections -- Central nervous system infections -- Skin and soft tissue infections -- Gastrointestinal infections and food poisoning -- Bone and joint infections -- Diseases of the reproductive organs and sexually transmitted diseases -- Eye infections -- Hepatitis -- Acquired immunodeficiency syndromes -- Miscellaneous syndromes --Vol. 2. -- Part III - Infectious diseases and their etiologic agents -- Viral diseases -- Prion diseases -- Chlamydial diseases -- Mycoplasma diseases -- Rickettsioses and ehrlichioses -- Bacterial diseases -- Mycoses -- Protozoal diseases -- Diseases due to toxic algae -- Diseases due to helminths -- Ectoparasitic diseases -- Diseases of unknown etiology -- Part IV - Special problems -- Nosocomial infections -- Infections in special hosts -- Surgical- and trauma-related infections -- Immunization -- Biodefense -- Zoonoses -- Protection of travelers -- The Internet.
  • "WHO has developed this manual in order to strengthen the laboratory diagnosis and virological surveillance of influenza infection by providing standard methods for the collection, detection, isolation and characterization of viruses"--Publisher's description.
  • John F. Enders and measles virus vaccine : a reminiscence / S.L. Katz -- Measles virus receptors / Y. Yanagi ... [et al.] -- Measles virus and CD46 / C. Kemper and J.P. Atkinson -- Measles virus glycoprotein complex assembly, receptor attachment, and cell entry / C.K. Navaratnarajah, V.H.J. Leonard and R. Cattaneo -- The measles virus replication cycle / B.K. Rima and W.P. Duprex -- Nucleocapsid structure and function / S. Longhi -- Reverse genetics of measles virus and resulting multivalent recombinant vaccines : applications of recombinant measles viruses / M.A. Billeter, H.Y. Naim and S.A. Udem -- Measles virus interaction with host cells and impact on innate immunity / D. Gerlier and H. Valentin.
  • Making it to the synapse : measles virus spread in and among neurons / V.A. Young and G.F. Rall -- Modeling subacute sclerosing panencephalitis in a transgenic mouse system : uncoding pathogenesis of disease and illuminating components of immune control / M.B.A. Oldstone -- Measles studies in the macaque model / R.L. de Swart -- Ferrets as a model for morbillivirus pathogenesis, complications, and vaccines / P. Pillet, N. Svitek and V. von Messling -- Current animal models : cotton rat animal model / S. Niewiesk -- Current animal models : transgenic animal models for the study of measles pathogenesis / C.I. Sellin and B. Horvat -- Molecular epidemiology of measles virus / P.A. Rota, D.A. Featherstone, and W.J. Bellini -- Human immunology of measles virus infections / D. Naniche -- Measles control and the prospect of eradication / W.J. Moss -- Measles : old vaccines, new vaccines / D.E. Griffin and C.-H. Pan -- Measles virus for cancer therapy / S.J. Russell and K.W. Peng -- Measles virus-induced immunosuppression / S. Schneider-Schaulies and J. Schneider-Schaulies -- Hostile communication of measles virus with host innate immunity and dendritic cells / B. Hahm.
  • Clinical, epidemiologic, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections / Elizabeth Palavecino -- MRSA case studies / Kurt D. Reed, Mary E. Stemper, and Sanjay K. Shukla -- MIC analysis and susceptibility testing of MRSA / German Bou -- ITS-PCR identification of MRSA / Shin-ichi Fujita -- Pulsed-field gel electrophoresis of methicillin-resistant Staphylococcus aureus / Kurt D. Reed, Mary E. Stemper, and Sanjay K. Shukla -- Multilocus sequence typing (MLST) of Staphylococcus aureus / Nicholas A. Saunders and Anne Holmes -- Staphylococcal cassette chromosome mec (SCCmec) analysis of MRSA / Teruyo Ito, Kyoko Kuwahara, and Keiichi Hiramatsu -- Targeted gene disruption for the analysis of virulence of Staphylococcus aureus / J. Ross Fitzgerald --Molecular analysis of staphylococcal superantigens / Patrick M. Schlievert and Laura C. Case -- Investigation of biofilm formation in clinical isolates of Staphylococcus aureus / James E. Cassat, Chia Y. Lee, and Mark S. Smeltzer -- Comparative analysis of staphylococcal adhesion and internalization by epithelial cells / Xudong Liang and Yinduo Ji -- Comparative analysis of MRSA / Fumihiko Takeuchi, Tadashi Baba, and Keiichi Hiramatsu -- Genomic analysis of gene expression of Staphylococcus aureus / Chuanxin Yu ... [et al.] -- Proteomic approach to investigate methicillin-resistant Staphylococcus aureus / Patrice Francois ... [et al.] -- Environmental surveillance for methicillin-resistant Staphylococcus aureus / J. Scott Weese -- The control and prevention of MRSA infections / Liangsu Wang and John F. Barrett -- Treatment of infections due to resistant Staphylococcus aureus / Gregory M. Anstead, Gabriel Quinones-Nazario, and James S. Lewis II.
  • Type of human disease by source of the infectious agent -- A history of zoonoses and sapronoses and research into them -- The infection process in zoonoses and sapronoses -- The epidemic process in zoonoses and sapronoses -- Haematophagous arthropods as vectors of diseases -- Vertebrates as hosts and reservoirs of zoonotic microbial agents -- Systematic survey of zoonoses and sapronoses microbial agents.
  • The second edition of Microbiology of Waterborne Diseases describes the diseases associated with water, their causative agents and the ways in which they gain access to water systems. The book is divided into sections covering bacteria, protozoa, and viruses. Other sections detail methods for detecting and identifying waterborne microorganisms, and the ways in which they are removed from water, including chlorine, ozone, and ultraviolet disinfection. The second edition of this handbook has been updated with information on biofilms and antimicrobial resistance. The impact of global warming and climate change phenomena on waterborne illnesses are also discussed. This book serves as an indispensable reference for public health microbiologists, water utility scientists, research water pollution microbiologists environmental health officers, consultants in communicable disease control and microbial water pollution students. Focuses on the microorganisms of most significance to public health, including E. coli, cryptosporidium, and enterovirus. Highlights the basic microbiology, clinical features, survival in the environment, and gives a risk assessment for each pathogen. Contains new material on antimicrobial resistance and biofilms. Covers drinking water and both marine and freshwater recreational bathing waters.
  • Biotechnology and the public health response to bioterrorism -- Historical perspectives of microbial bioterrorism -- The infectious disease physician and microbial bioterrorism -- Modulation of innate immunity to protect against biological weapon threat -- Smallpox: pathogenesis and host immune responses relevant to vaccine and therapeutic strategies -- Bacillus anthracis: agent of bioterror and disease -- Tularemia pathogenesis and immunity -- Brucella and bioterrorism -- Pneumonic plague -- Coxiella burnetii, Q fever, and bioterrorism -- Genomic and proteomic approaches against Q fever -- Rickettsia rickettsii and other members of the spotted fever group as potential bioweapons.
  • Part 1. Challenges -- The Global Burden of Infectious Diseases / Paulo Pinheiro, Colin D. Mathers and Alexander Krämer -- Global Challenges of Infectious Disease Epidemiology / Alexander Krämer and Md. Mobarak Hossain Khan -- Emerging and Re-emerging Infectious Diseases / Thomas Löscher and Luise Prüfer-Krämer -- Infectious Disease Control Policies and the Role of Governmental and Intergovernmental Organisations / Gérard Krause -- Part 2. General concepts and methods -- Principles of Infectious Disease Epidemiology / Alexander Krämer, Manas Akmatov and Mirjam Kretzschmar -- Social Risk Factors / Klaus Krickeberg and David Klemperer -- Molecular Typing and Clustering Analysis as a Tool for Epidemiology of Infectious Diseases / Sylvia M. Bruisten and Leo Schouls -- Epidemiologic Surveillance / Ralf Reintjes and Klaus Krickeberg -- Outbreak Investigations / Ralf Reintjes and Aryna Zanuzdana -- Geographic Information Systems / Patrick Hostert and Oliver Gruebner -- Methods and Concepts of Epidemiology / Rafael Mikolajczyk -- Mathematical Models in Infectious Disease Epidemiology / Mirjam Kretzschmar and Jacco Wallinga -- Immunity to Infectious Diseases / Timo Ulrichs -- Principles and Practice of Vaccinology / Richard Pebody and Mirjam Kretzschmar -- Health Economics of Infectious Diseases / Robert Welte, Reiner Leidl, Wolfgang Greiner and Maarten Postma -- Part 3. Epidemiology of particular infectious diseases -- Airborne Transmission: Influenza and Tuberculosis / Timo Ulrichs -- Infectious Childhood Diarrhea in Developing Countries / Charles P. Larson, Lars Henning, Stephen Luby and Asg Faruque -- Bloodborne and Sexual Transmission: HIV/AIDS / Charlotte van den Berg, Karen Lindenburg and Roel Coutinho -- Blood Borne and Sexual Transmission: Hepatitis B and C / Freke Zuure, Susan Hahné, Thijs van de Laar, Maria Prins and Jim van Steenbergen -- Sexual Transmission: Chlamydia trachomatis / Robert E. Johnson and Stuart M. Berman -- Vector-Borne Transmission: Malaria, Dengue, and Yellow Fever / Tomas Jelinek -- Nosocomial Transmission: Methicillin-Resistant Staphylococcus aureus (MRSA) / M.J.M. Bonten and M.C.J. Bootsma -- Infectious Diseases and Cancer: HPV / Helen Trottier and Eduardo L. Franco.
  • The diagnosis and management of infectious diseases -- Nose and throat syndromes -- Infectious mononucleosis and mononucleosis-like syndromes -- Mouth and salivary gland syndromes -- Eye, ear, and sinus syndromes -- Face and neck syndromes -- Middle respiratory syndromes -- Pneumonia syndromes -- Neurologic syndromes -- Fever and shock syndromes -- Rash syndromes -- Gastrointestinal syndromes -- Hepatitis syndromes -- Urinary syndromes -- Genital syndromes -- Orthopedic syndromes -- Skin syndromes -- Cardiovascular syndromes -- Perinatal syndromes -- HIV infection and AIDS -- Exposure problems -- Infections complicating chronic diseases -- The child with frequent, severe, or unusual infections: congenital immunodeficiency syndromes.
  • Genetic analysis of bacterial pathogenesis -- Genetic exchance in bacteria and the modular stucture of mobile DNA elements -- Genomics and the use of genomic tools to study pathogenic bacteria -- Pathogenicity islands and bacterial virulence -- Capsules -- Bacterial cell walls -- Mechanisms of bacterial adhesion and consequences of attachment -- Bacterial invasion into non-phagocytic cells -- Bacterial protein secretion mechanisms -- Toxins as host cell modulators -- Quorum sensing: coordinating group behavior through intercellular signals -- The role of sigma factors in regulating bacterial stress responses and pathogenesis -- Two-component regulatory systems -- Oxidative stress systems in bacteria: four model organisms -- Bacterial biowarfare agents.
  • The application of modern molecular genetic and biologic techniques to infectious disease epidemiology dramatically improves measurement of disease and putative risk factors increasing our ability to detect and track outbreaks, identify risk factors and detect new infectious agents. However, integration of these techniques into epidemiologic studies also poses new challenges in the design, conduct, and analysis. We examine these opportunities and methodologic challenges giving specific examples. The book will be written for the reader with limited understanding of genetics, biology and epidemiology. *Presents the key points of consideration when integrating molecular biology and epidemiology *Discusses how using molecular tools in epidemiologic research affects program design and conduct *Considers the ethical concerns that arise in molecular epidemiologic studies *Provides a context for understanding and interpreting scientific literature as a foundation for subsequent practical experience in the laboratory and in the field.
  • In contrast to the substantial literature that focuses upon innate immune signaling in the gut, there is remarkably less known about the response of the airway to bacterial pathogens. The purpose of this book will be to review the current status of theunderstanding of the pathogenesis of acute bacterial pneumonia, slanted toward the mucosal immunology of these infections. It will describe, in general, the signaling cascades that control the proinflammatory response to bacterial infection in the lung. How innate immune signaling is orchestrated in response to specific common airway pathogens is addressed, targeting Staphylococus aureus (including MRSA), Streptococcus pneumoniae and Klebsiella pneumoniae. By describing the general immunological responses to conserved bacterial components and then detailing how specific organisms cause infection, this book provides a targeted but comprehensive review of this important topic.
  • v. 2, 2009 Springer
    v. 3, 2010 Springer
    v. 1. Frontiers in research -- v. 2. Impact on Global Health -- v. 3. Intramural research.
  • Herpes viruses -- Myxoviruses -- Picornaviruses -- Arboviruses -- Togaviruses -- Rhabdoviruses -- Adenoviruses -- Arenaviruses -- Orthopoxviruses -- Retroviruses -- Neurological consequences of antiretroviral treatment -- Papovaviruses -- Bacterial meningitis -- Focal bacterial infections and parameningeal infections -- Streptococcus pyogenes -- Bordetella petussis -- Shigella species -- Campylobacter species -- Brucella species -- Clostridium tetani -- Clostridium botulinum -- Corynebacterium diphtheriae -- Bartonella species -- Mycobacterium tuberculosis -- Mycobacterium leprae -- Rickettsia rickettsii -- Ehrlichia and Anaplasma species -- Borrelia burgdorferi -- Treponema pallidum -- Candida species -- Cryptococcus neoformans -- Histoplasma capsulatum -- Coccidiodes species -- Phaeohyphomycoses -- Protozoal infections -- Babesia species -- Helminth infections -- Neurological disease and primary immunodeficiency -- Basic principles of selective neurological treatments.
  • Neuroviral infections : a historical perspective -- Neuroviral infections and immunity -- Controlling neuroinflammation : lessons from rabies virus -- Laboratory diagnosis of CNS viral infections -- New trends in antiviral therapy of CNS infections -- Animal models of viral encephalitis -- Herpes simplex virus and human CNS infections -- CNS, neurological infections caused by the herpes virus Varicella zoster virus (VZV) and models of VZV-neurotropism -- Epstein- Barr virus and CNS infections -- Cytomegalovirus (CMV) infection -- Human herpesvirus 6A, 6B, and 7 encephalitis -- The human polyomavirus JC and progressive multifocal leukoencephalopathy.
  • Alphavirus neurovirulence -- Neurological chikungunya : lessons from recent epidemics, animal models, and other alphavirus family members -- Arenaviruses and neurovirology -- Bunyaviruses -- Human coronaviruses : respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents -- Non-polio enteroviruses, polioviruses, and human CNS infections -- Neurovirulence of West Nile Virus -- Murray Valley encephalitis virus -- Japanese encephalitis virus and human CNS infection -- Tick Borne Encephalitis Virus (TBEV) infection -- Saint Louis encephalitis -- Powassan virus infection -- Neurological Dengue -- Influenza virus and CNS infections -- Human paramyxoviruses and infections of the central nervous system -- Rabies virus neurovirulence -- Rubella virus infections -- Human T-lymphotropic virus -- Human Immunodeficiency Virus (HIV) neuropathogenesis.
  • Methods and tools in molecular epidemiology -- Molecular typing of bacterial pathogens: a tool for the epidemiological study and control of infectious diseases -- Contribution of population genetics -- Molecular epidemiology and evolutionary genetics of infectious diseases -- Population genetics and molecular epidemiology of infectious diseases -- Contribution of population and evolutionary epidemiology -- Modelling the dynamics of host-parasite interactions: basic principles -- Evolution of virulence: intuitions and models -- Case studies -- Molecular epidemiology of tuberculosis -- Pneumocystis molecular phylogeny: a way to understand both pneumocystosis natural histry and host taxonomy -- Hantavirus genetic diversity -- New integrations -- Nasal carriage of methicillin-resistant coagulase-negative staphylocococci: a reservoir of mecA gene for Staphylococcus aureus -- Molecular knowledge of mechanisms of helminth resistance: importance for diagnostic and epidemiology -- Molecular epidemiology of disease resistance genes with perspectives for researches on biological invasions and hybrid zones -- How does biodiversity influence the ecology of infectious disease? -- Epidemiological interaction at the wildlife/livestock/human interface: can we anticipate emerging infectious diseases in their hotspots? A framework for understanding emerging diseases processes in their hot spots.
  • Influenza pandemics are unpredictable but recurring events that can have severe consequences on societies worldwide. This revised WHO guidance publication on pandemic influenza preparedness and response acknowledges that pandemic preparedness is centered around health sectors planning but must also be broader. WHO therefore advocates a "whole-of-society" approach to sustainable and ethical pandemic preparedness while focusing in more detail on the role of the health sector. The roles of WHO and national governments are outlined to create a better understanding of how health and non-health sectors, both public and private, all contribute to pandemic preparedness.--Publisher's description.
  • Mycobacterium tuberculosis is one of the most notorious pathogens on earth, causing the death of approximately 1.5 million people annually. A major problem in the fight against tuberculosis is the emergence of strains that have acquired resistance to all available antibiotics. One key to the success of M. tuberculosis as a pathogen is its ability to circumvent host immune responses at different levels. This is not only a result of the special makeup of M. tuberculosis in terms of genetic diversity and DNA metabolism and its possession of specialized secretion systems, but also of its ability to hijack the host's innate immune defence mechanisms. In this volume, researchers from different disciplines provide a topical overview of the diverse mechanisms that contribute to the virulence of M. tuberculosis, ranging from their genetic, metabolic and molecular makeup, as well as the complex strategies these bacteria utilize to escape immune destruction within infected hosts.
  • Ch. 1. Enteroviruses -- Ch. 2. Rhinoviruses -- Ch. 3. Influenza viruses -- Ch. 4. Parainfluenza viruses -- Ch. 5. Respiratory syncytial virus (RSV) -- Ch. 6. Herpesviruses: general principles -- Ch. 7. Herpes simplex virus (HSV) types 1 and 2 -- Ch. 8. Cytomegalovirus -- Ch. 9. Epstein-Barr virus (EBV) -- Ch. 10. Varicella-Zoster virus (VZV) -- Ch. 11. Herpesvirus type 6 (HHV-6) -- Ch. 12. Kaposi sarcoma-associated herpesvirus (KSHV, HHV-8) -- Ch. 13. Herpesvirus simiae virus (Herpes B) -- Ch. 14. Adenoviruses -- Ch. 15. Retroviruses: general principles -- Ch. 16. Human immunodeficiency viruses -- Ch. 17. Human T cell leukemia/lymphoma viruses (HTLV-1 and -2) -- Ch. 18. Hepatitis viruses -- Ch. 19. Hemorrhagic fever viruses -- Ch. 20. Hantavirus pulmonary syndrome (HPS) -- Ch. 21. Papillomaviruses -- Ch. 22. Papovaviruses -- Ch. 23. Parvoviruses -- Ch. 24. Neurotropic arthropod-transmitted viruses -- Ch. 25. Rabieviruses -- Ch. 26. Poxviruses -- Ch. 27. Mumps -- Ch. 28. Rubellavirus -- Ch. 29. Rubeola (measles) -- Ch. 30. Transmissible spongiform encephalopathy -- Ch. 31. Lymphocytic choriomeningitis virus (LCMV) -- Ch. 32. Enteric viral disease.
  • Bridging the divide: population mobility and the emergence of disease. Demographic and epidemiological perspectives of human movement / Yorghos Apostolopoulos and Sevil Sönmez -- Key themes pertinent to migration, health, and disease. Population mobility and the geography of microbial threats / Mary E. Wilson -- Health barriers and inequities for migrants / Elizabeth Ioannidi-Kapolou -- Social networks, social capital, and HIV risks among migrants / Varda Soskolne -- Labor induced migration and disease diffusion. Economic migrants and health vulnerability / Mark N. Lurie -- Military personnel: on the move and vulnerable/AIDS to HIV and other STIs / Stuart J. Kingma and Rodger D. Yeager -- Selling sex in the era of AIDS: mobile sexworkers and STI/HIV risks / Natalya Timoshkina, Anthony P. Lombardo, and Lynn McDonald -- Tracing the diffusion of infectious diseases in the transport sector / Yorghos Apostolopoulos and Sevil Sönmez -- Forced migration: a public health catastrophe. War, refugees, migration, and public health: do infectious diseases matter? / Frederick M. Burkle -- Natural disasters, climate change, and the health of mobile populations / Jonathan D. Mayer -- Leisure migration and health concerns: a paradox or inevitability? Casual sex in the sun makes the holiday: young tourists' perspectives / Eugenia Wickens and Sevil Sönmez -- In search of the exotic: sex tourism and disease risks / Sevil Sönmez, Eugenia Wickens, and Yorghos Apostolopoulos -- New directions in migration health and medicine. Mapping and modeling disease risk among mobile populations / Henry G. Mwambi and Khangelani Zuma -- Ethical and legal issues impacting migrant health / Sana Loue -- Migration in a mobile world: health, population mobility, and emerging disease / Brian D. Gushulak and Douglas W. MacPherson.
  • Poxviruses 2007, Springer
  • Infections in patients with cancer : overview / Amar Safdar, Gerald Bodey, and Donald Armstrong -- Infections in hematopoietic stem cell transplant recipients / Georg Maschmeyer and Per Ljungman -- Infections in patients with hematologic malignancies / Genovefa Papanicolaou and Jayesh Mehta -- Infections in solid tumor patients / Alison G. Freifeld -- Infections in patients with hematologic malignancies treated with monoclonal antineoplastic therapy / André Goy and Susan O'Brien -- Postsurgery infections in cancer patients / Emilio Bouza ... [et. al] -- Management of infections in critically ill cancer patients / Henry Masur -- Management of the neutropenic patient with fever / Kenneth V. I. Rolston and Gerald P. Bodey -- Controversies in empiric therapy of febrile neutropenia / John R. Wingard -- Catheter-related infections in cancer patients / Iba Al Wohoush, Anne-Marie Chaftari, and Issam Raad -- Intravascular device-related infections : catheter salvage strategies and prevention of device-related infection / Nasia Safdar and Dennis G. Maki -- Pneumonia in the cancer patient / Scott E. Evans and Amar Safdar -- Noninfectious lung infiltrates that may be confused with pneumonia in the cancer patient / Rana Kaplan ... [et. al] -- Mucosal barrier injury and infections / Nicole M. A. Blijlevens and J. Peter Donnelly -- Bacterial colonization and host immunity / Coralia N. Mihu, Karen J. Vigil, and Javier A. Adachi -- Neutropenic enterocolitis and clostridium difficile infections / Amar Safdar ... [et. al] -- Management of reactivation of hepatitis B and hepatitis C during antineoplastic therapy / Marta Davila and Harrys A. Torres -- Management of genitourinary tract infections / Amar Safdar and Maurie Markman -- Central nervous system infections in cancer patients / Victor Mulanovich and Amar Safdar -- Endocarditis in oncology patients / Sara E. Cosgrove and Aruna Subramanian -- Skin disorders difficult to distinguish from infections / Sharone Hymes, Susan Chon, and Ana Ciurea -- Overview of invasive fungal disease in oncology patients / Amar Safdar -- Diagnosis of invasive fungal disease / Dionissios Neofytos and Kieren Marr -- Invasive candidiasis in management of infections in cancer patients / Matteo Bassetti ... [et. al] -- Management of aspergillosis, zygomycosis, and other clinically relevant mold infections / Konstantinos Leventakos and Dimitrios P. Kontoyiannis -- Cryptococcal disease and endemic mycosis / Johan A. Maertens and Hélène Schoemans -- Current controversies in the treatment of fungal infections / Christopher D. Pfeiffer, John R. Perfect, and Barbra D. Alexander --Fungal drug resistance and pharmacologic considerations of dosing newer antifungal therapies / Russell E. Lewis and David S. Perlin -- Immunotherapy for difficult-to-treat invasive fungal diseases / Brahm H. Segal, Amar Safdar, and David A. Stevens -- Cytomegalovirus in patients with cancer / Morgan Hakki, Per Ljungman, and Michael Boeckh -- Epstein-Barr virus, varicella zoster virus, and human herpes viruses-6 and -8 / Mini Kamboj and David M. Weinstock -- Respiratory viruses / Roy F. Chemaly, Dhanesh B. Rathod, and Robert Couch -- BK, JC and parvovirus infections in patients with hematologic malignancies / Véronique Erard and Michael Boeckh -- Antiviral resistance and implications for prophylaxis / Robin K. Avery -- Management of gram-positive bacterial disease : staphylococcus aureus, streptococcal, pneumococcal, and enterococcal infections / Samuel Shelburne and Daniel M. Musher -- Infections caused by aerobic and anaerobic gram-negative bacilli / Kenneth V. I. Rolston, David E.Greenberg, and Amar Safdar -- Listeriosis and nocardiosis / Heather E. Clauss and Bennett Lorber -- Antibacterial distribution and drug-drug interactions in cancer patients / Ursula Theuretzbacher and Markus Zeitlinger -- Mycobacterium tuberculosis infection / Michael Glickman -- Nontuberculous mycobacterial infections / Amar Safdar -- Parasitic infections in cancer patients : toxoplasmosis, strongyloidiasis and other parasites / Brian G. Blackburn and José G. Montoya -- Zoonoses in cancer patients / Donald Armstrong -- Antibiotic stewardship : considerations for a cancer Center / Coralia N. Mihu, Alla Paskovaty, and Susan K. Seo -- Controversies in antimicrobial stewardship / Graeme N. Forrest -- Prevention of antimicrobial resistance : current and future strategies / Cesar A. Arias and Adolf W. Karchmer -- Antibacterial, antifungal, and antiviral prophylaxis / Marcio Nucci and John R. Wingard -- Controversies in antimicrobial prophylaxis / Ben de Pauw and Marta Stanzani -- Infection prevention : protected environment and infection control / J. Peter Donnelly -- Prevention of tropical and parasitic infections : the immunocompromised traveler / Francesca F. Norman and Rogelio López-Vélez -- Prophylactic vaccination of cancer patients and hematopoietic stem cell transplant recipients / William Decker and Amar Safdar.
  • Pt. 1. Understanding, controlling, and preventing infectious diseases. -- Pt.2. Clinical syndromes and cardinal features of infectious diseases: approach to diagnosis and initial management. -- Pt.3. Etiologic agents of infectious diseases. -- Pt.4. Laboratory diagnosis and therapy of infectious diseases.
  • Thirty years since Estelle v. Gamble: looking forward, not wayward / Robert B. Greifinger -- Impact of incarceration on community public safety and public health / Todd R. Clear -- Litigating for better medical care / Jon Wool -- Accommodating disabilities in jails and prisons / R. Samuel Paz -- Growing older: challenges of prison and reentry for the aging population / Brie Williams, Rita Abraldes -- International public health and corrections: models of care and harm minimization / Michael Levy -- The medicalization of execution: lethal injection in the United States / Mark Heath -- HIV and viral hepatitis in corrections: a public health opportunity / Joseph A. Bick -- Prevention of viral hepatitis / Cindy Weinbaum, Karen A. Hennessey -- HIV prevention: behavioral interventions in correctional settings / Barry Zack -- Prevention and control of tuberculosis in correctional facilities / Farah M. Parvez -- Controlling chlamydia, gonorrhea, and syphilis through targeted screening and treatment in correctional settings / Charlotte K. Kent, Gail A. Bolan -- Health promotion in jails and prisons: an alternative paradigm for correctional health services / Megha Ramaswamy, Nicholas Freudenberg -- Screening for public purpose: promoting an evidence-based approach to screening of inmates to improve the public health / Joshua D. Lee, Marshall W. Fordyce, Josiah D. Rich -- Written health informational needs for reentry / Jeff Mellow -- Reducing inmate suicides through the mortality review process / Lindsay M. Hayes -- Blinders to comprehensive psychiatric diagnosis in the correctional system / Richard L. Grant -- Juvenile corrections and public health collaborations: opportunities for improved health outcomes / Michelle Staples-Horne, Kaiyti Duffy, Michele T. Rorie -- Female prisoners and the case for gender-specific treatment and reentry programs / Andrea F. Balis -- Building the case for oral health care for prisoners: presenting the evidence and calling for justice / Henrie M. Treadwell, Mary E. Northridge, Traci N. Bethea -- Treatment of mental illness in correctional settings / Raymond F. Patterson, Robert B. Greifinger -- Treatment and reentry approaches for offenders with co-occurring disorders / Roger H. Peters, Nicole M. Bekman -- Pharmacological treatment of substance abuse in correctional facilities: prospects and barriers to expanding access to evidence-based therapy / R. Douglas Bruce, Duncan Smith-Rohrberg, Frederick L. Altice -- Health research behind bars: a brief guide to research in jails and prisons / Nicholas Freudenberg -- Reentry experiences of men with health problems / Christy A. Visher, Kamala Mallik-Kane -- Providing transition and outpatient services to the mentally ill released from correctional institutions / Steven K. Huge -- Sexual predators: diversion, civil commitment, community reintegration, challenges, and opportunities / Karen Terry -- Electronic health records systems and continuity of care / Ralph P. Woodward -- Community health and public health collaborations / Thomas Lincoln, John R. Miles, Steve Scheibel -- Improving the care for HIV-infected prisoners: an integrated prison-release health model / Sandra A. Springer, Frederick L. Altice.
  • Public health entomology 2013, CRCnetBASE
    "Increasing problems of emerging and re-emerging infectious diseases, brought about, at least in part, by vectors fueled by increased worldwide travel and commerce, make this a highly timely book for anyone in the public practice of medical and veterinary entomology, including entomologists, public health officials, and pest control technicians and managers. Employing a reader-friendly style with bulleted texts, scenarios, and case history boxes, it targets the major vectors and pests of medical and public health importance, addresses regulatory and academic medical entomology, and discusses disease vector control with worldwide application"--Provided by publisher.
  • Rabies 2002, ScienceDirect
  • History of rabies research -- Rabies virus -- Epidemiology -- Molecular epidemiology -- Rabies in terrestrial animals -- Bat rabies -- Human disease -- Pathogenesis -- Pathology -- Immunology -- Laboratory diagnosis of rabies -- Measures of rabies immunity -- Rabies vaccines -- Next generation of rabies vaccines -- Public health management of humans at risk -- Therapy of human rabies -- Dog rabies and its control -- Rabies control in wild carnivores -- Blueprint for rabies prevention and control -- Future developments and challenges.
  • A novel strain of influenza A (H1N1) virus emerged and an outbreak of influenza A (H1N1) occurred worldwide in 2009 and 2010, posing a severe threat to the health of human beings. The two Editors work together in Beijing You An Hospital, to combat this type of influenza. This book, Radiology of Influenza A (H1N1), is intended to provide first-hand clinical data and its scientific analysis, thus supporting sound clinical practice for influenza A (H1N1) prevention and treatment as well as related scientific research. The authors have collected over 100 critical influenza A (H1N1) virus-infected cases. For cases of influenza A (H1N1) that resulted in death, autopsies were performed for 8 cases after receiving their families' informed consent. Over 200 reports on pathological and histological analysis as well as immunohistochemical and electroscopic analysis were brought together. This book was then compiled by comparing the published data with the present first-hand data. This book includes a wealth of content, including DR, CT and MRI images, pathological and histological figures, and immunohistochemical and electroscopic figures. Related research, clinical and educational needs can be readily satisfied by its detailed data, texts and figures, as well as typical case reports. Li Hongjun, is professor and director of the diagnostic radiology department in Beijing You An Hospital, affiliated with Capital Medical University, Beijing, China. Li Ning, is professor and president of Beijing You An Hospital, affiliated with Capital Medical University, Beijing, China.
  • The Rapids are a series of reference and revision pocket books that cover key facts in a simple and memorable way. Each book contains the common conditions that students and newly qualified nurses encounter on the wards, in the community, and on placements. Only the basic core relevant facts are provided to ensure that these books are perfect and concise rapid refreshers. Rapid Infection Control Nursing is an essential read for all frontline nursing staff working in hospitals or community settings. Designed for quick reference, it explores the essential principles of infection.
  • Red book online HighWire, Latest ed. only
    Red Book Online is the online home of the Report of the AAP Committee on Infectious Diseases. Offering instant Web-based access, Includes complete text of the Red Book, plus the complete visual library of images from the Visual Red Book on CD-ROM and more.
  • Refugee health care 2014, Springer
    "Physicians receive very little training in refugee health. Refugee Health Care is a practical guide providing concise information for busy practitioners. This concise textbook reviews common conditions seen in refugees and some of the recommendations in the book apply to all immigrants. It will be a valuable resource for primary care physicians, psychiatrists, pediatricians, women's health providers and any health care practitioner who treats refugees."--Publisher's website.
  • Replicating vaccines 2011, Springer
    Live vaccines and their role in modern vaccinology / Gordon Dougan, David Goulding, and Lindsay J. Hall -- Live attenuated vaccines : influenza, rotavirus and varicella zoster virus / Harry B. Greenberg and Ann M. Arvin -- Classical live viral vaccines / Thomas P. Monath -- Recombinant live vaccines to protect against the severe acute respiratory syndrome coronavirus / Luis Enjuanes ... [et al.] -- Live-attenuated Shigella vaccines. Is encouraging good enough? / Yves Germani and Philippe J. Sansonetti -- New generation BCG vaccines / Michael V. Tullius and Marcus A. Horwitz -- Basic science paves the way to novel safe and effective pestivirus vaccines / Norbert Tautz and Gregor Meyers -- Live attenuated influenza virus vaccines : NS1 truncation as an approach to virus attenuation / Natalie Pica, Peter Palese, and John Steel -- An attenuated HSV-1 live virus vaccine candidate that is replication competent bu defective in epithelial cell-to-cell and neuronal spread / Elizabeth E. Zumbrun and Harvey M. Frieman -- Live attenuated vaccines for respiratory syncytial virus / Michael N. Teng -- Live attenuated cholera vaccines : flagella and reactogenicity / D. Ewen Cameron and John J. Mekalanos -- Replication-defective herpes simplex virus mutant strains as genital herpes vaccines and vaccine vectors / David M. Knipe -- Nucleic acid-based infections and pseudo-infectious flavivirus vaccines / Justin A. Roby, Roy A. Hall, and Alexander A. Khromykh -- Application of cleavage activation mutants of influenza virus as live vaccines / Juergen Stech and Hans-Dieter Klenk -- Alphavirus particle-based vaccine vectors / Scott J. Balsitis, Clayton W. Beard, and Peter W. Mason -- Recombinant chimeric, live attenuated vaccines against flaviviruses and alphaviruses / Thomas P. Monath.
  • Red Book Online is the online home of the Report of the AAP Committee on Infectious Diseases. Offering instant Web-based access, Includes complete text of the Red Book, plus the complete visual library of images from the Visual Red Book on CD-ROM and more.
  • Mechanisms of apoptosis during reovirus infection /P. Clarke ... [et al.] --Poliovirus, pathogenesis of poliomyelitis, and apoptosis /B. Blondel ... [et al.] --Neuronal cell death in alphavirus encephalomyelitis /D. E. Griffin --HSV-induced apoptosis in herpes encephalitis /L. Aurelian --Therole of apoptosis in defense against baculovirus infection in insects /R. J. Clem --Therole of host cell death in Salmonella infections /D. G. Guiney --Role of macrophage apoptosis in the pathogenesis of Yersinia /Y. Zhang, J. B. Bliska --Entamoeba histolytica activates host cell caspases during contact-dependent cell killing /D. R. Boettner, W. A. Petri --Interactions between malaria and mosquitoes : the role of apoptosis in parasite establishment and vector response to infection /H. Hurd, V. Carter, A. Nacer --Apoptosis and its modulation during infection with Toxoplasma gondii : molecular mechanisms and role in pathogenesis /C. G. K. Luder, U. Gross --Modulation of the immune response in the nervous system by rabies virus /M. Lafon --Apoptotic cells at the crossroads of tolerance and immunity /M. Skoberne ... [et al.].
  • Schistosomiasis 2005, Springer
  • Secret agents 2002, NAP
    Disease in disguise -- Winged victories -- Food fright -- Superbugs -- The once and future pandemic -- Infection unmasked -- Bioterror.
  • Sepsis 2008, Springer
  • Sepsis. 2nd ed. 2006, Springer
  • Sex differences in susceptibility to infection : an evolutionary perspective / Marlene Zuk and Andrew M. Stoehr -- Effects of sex steroids on innate and adaptive immunity / S. Ansar Ahmed, Ebru Karpuzoglu, and Deena Khan -- Sex steroid receptors in immune cells / Susan Kovats, Esther Carreras, and Hemant Agrawal -- Sex differences in susceptibility to viral infection / Sabra L. Klein and Sally Huber -- Sex differences in innate immune responses to bacterial pathogens / Jennifer A. Rettew, Ian Marriott, and Yvette M. Huet -- Sex hormones and regulation of host responses against parasites / James Alexander ... [et al.] -- Sex differences in parasitic infections : beyond the dogma of female-biased resistance / Galileo Escobedo, Marco A. De León, and Jorge Morale-Montor -- Progesterone, pregnancy, and innate immunity / Julia Szekeres-Bartho and Beata Polgar -- Pregnancy and susceptibility to parasites / Fiona L. Henriquez, Fiona M. Menzies, and Craig W. Roberts -- Sex steroids and risk of female genital tract infection / Patti Gravitt and Khalil Ghanem -- Sex, pregnancy, and measles / Allison C. Brown and William J. Moss -- Epilogue : challenges for the future / Craig W. Roberts and Sabra L. Klein.
  • Print Material
  • The nature of infection / Kenneth J. Ryan and C. George Ray -- Pathogenic viruses / Nafees Ahmad, C. George Ray, and W. Lawrence Drew -- Pathogenic bacteria / Kenneth J. Ryan and W. Lawrence Drew -- Pathogenic fungi / Kenneth J. Ryan -- Pathogenic parasites / C. George Ray and James J. Plorde -- Clinical aspects of infection / C. George Ray, Kenneth J. Ryan, and W. Lawrence Drew.
  • Smallpox, a history 2013, ebrary
    "Scientifically known as Variola major, the deadliest form of smallpox has plagued mankind since 'time immemorial.' This text chronicles the worldwide effects of the killer disease, with particular emphasis on the 19th and 20th centuries, including the devastations of the "speckled disease" during great armed conflicts"--Provided by publisher.
  • "The second WHO report builds on the growing sense of optimism generated by the 2012 publication of the WHO roadmap. Commitments on the part of ministries of health in endemic countries, global health initiatives, funding agencies and philanthropists have escalated since 2010, as have donations of medicines from pharmaceutical companies and the engagement of the scientific community. This report marks a new phase and assesses opportunities and obstacles in the control, elimination and eradication of several of these diseases. Unprecedented progress over the past two years has revealed unprecedented needs for refinements in control strategies, and new technical tools and protocols. The substantial increases in donations of medicines made since the previous report call for innovations that simplify and refine delivery strategies. However, some diseases, including especially deadly ones like human African trypanosomiasis and visceral Leishmaniasis, remain extremely difficult and costly to treat. The control of Buruli ulcer, Chagas disease and yaws is hampered by imperfect technical tools, although recent developments for yaws look promising. The report highlights progress against these especially challenging diseases, being made through the development of innovative and intensive management strategies. innovations in vector control deserve more attention as playing a key part in reducing transmission and disease burden, especially for dengue, Chagas disease and the Leishmaniases. Achieving universal health coverage with essential health interventions for neglected tropical diseases will be a powerful equalizer that abolishes distinctions between the rich and the poor, the young and the old, ethnic groups, and women and men."--P. 4 of cover.
  • Pt. I. Principles of taxonomy. The magnitude and diversity of infectious diseases -- What is a classification? -- The tree of life -- pt. II. Bacteria. Overview of Class Bacteria -- The Alpha Proteobacteria -- Beta Proteobacteria -- Gamma Proteobacteria -- Epsilon Proteobacteria -- Spirochaetes -- Bacteroidetes and Fusobacteria -- Mollicutes -- Class Bacilli plus Class Clostridia -- Chlamydiae -- Actinobacteria -- pt. III. Eukaryotes. Overview of Class Eukaryota -- Metamonada -- Euglenozoa -- Percolozoa -- Apicomplexa -- Ciliophora (ciliates) -- Heterokontophyta -- Amoebozoa -- Choanozoa -- Archaeplastida -- pt. IV. Animals. Overview of Class Animalia -- Platyhelminthes (flatworms) -- Nematoda (roundworms) -- Acanthocephala -- Chelicerata -- Hexapoda -- Crustacea -- Craniata -- pt. V. Fungi. Overview of Class Fungi -- Zygomycota -- Basidiomycota -- Ascomycota -- Microsporidia -- pt. VI. Nonliving infectious agents : viruses and prions. Overview of viruses -- Group I viruses : double-stranded DNA -- Group II viruses : single-stranded (+)sense DNA -- Group III viruses : double-stranded RNA -- Group IV viruses : single-stranded (+)sense RNA -- Group V viruses : single stranded (-)sense RNA -- Group VI viruses : single-stranded RNA reverse transcriptase viruses with a DNA intermediate in life-cycle -- Group VII viruses : double stranded DNA reverse transcriptase viruses -- Prions -- Appendices : I. Additional notes on taxonomy -- II. Number of occurrences in some common infectious diseases -- III. Organisms causing infectious disease in humans.
  • Toxoplasma gondii. 2nd edition. 2014, ScienceDirect
    This book reflects the significant advances in the field in the last 5 years, including new information on the genomics, epigenomics and proteomics of T. gondii as well as a new understanding of the population biology and genetic diversity of this organism.
  • Tropical Infectious Diseases: Principles, Pathogens and Practice, by Drs. Richard L. Guerrant, David H. Walker, and Peter F. Weller, delivers the expert, encyclopedic guidance you need to overcome the toughest clinical challenges in diagnosing and treating diseases caused by infectious agents from tropical regions. Sweeping updates to this 3rd edition include vaccines, SARS, hepatitis A-E, Crimean-Congo hemorrhagic fever virus, tick-borne encephalitis and Omsk hemorrhagic fever, human papilloma virus, and mucormycosis. New full-color images throughout allow you to more accurately view the clinical manifestations of each disease and better visualize the life cycles of infectious agents. And, full-text online access at www.expertconsult.com enables you to perform quick searches and rapidly locate and download images. Definitive, state-of-the-art coverage of pathophysiology as well as clinical management makes this the reference you'll want to consult - online and in print - whenever you are confronted with tropical infections, whether familiar or unfamiliar! Obtain complete and trustworthy advice from hundreds of the leading experts on tropical diseases worldwide, including cutting-edge summaries of pathophysiology and epidemiology as well as clinical management.
  • Machine generated contents note: pt. I Encephalitis -- Measles Virus Infection and Subacute Sclerosing Panencephalitis / Kalbiye Yalaz -- Epstein-Barr Virus and Cytomegalovirus Infections / Alex Tselis -- Herpes Simplex Virus Meningoencephalitis / Israel Steiner -- Progressive Multifocal Leukoencephalopathy / Allen J. Aksamit -- Varicella Zoster Virus Infections / Don Gilden -- pt. II Meningitis/Encephalitis/Poliomyelitis -- Enterovirus Infections / Burk Jubelt -- pt. III Retroviruses -- Human Immunodeficiency Virus Infection/AIDS / William Tyor -- Human T-Cell Lymphotropic Virus Type 1 Infection / Raya Massoud -- pt. IV Viral Zoonoses -- Rabies / Alan C. Jackson -- West Nile Virus Infection / Marc Fischer -- Japanese Encephalitis Virus Infection / Tom Solomon -- Chikungunya Virus Infection / Philippe Gasque -- Nipah Virus Infection / Chong-Tin Tan -- Viral Hemorrhagic Fevers / Marylou V. Solbrig -- pt. V Unconventional Agents -- Prion Diseases / Valerie L. Sim.
  • 1. Introduction -- 2. Policies, strategies and targets for malaria control -- 3. Interventions to control malaria -- 4. Impact of malaria control -- 5. Elimination of malaria -- 6. Financing malaria control -- PROFILES -- 31 high-burden countries -- -- Annex 1. Methods for preparing the country profiles -- Annex 2. Reported malaria cases and deaths, 2008 -- Annex 3. A. Reported malaria cases, 1990--2008 -- Annex 3. B. Reported malaria deaths, 1990--2008 -- Annex 4. A. Recommended policies and strategies for malaria control, 2009 -- Annex 4. B. Antimalarial drug policy, 2009 -- Annex 5. Operational coverage of ITNs, IRS and antimalarial treatment, 2007--2008 -- Annex 6. A. Household surveys of mosquito nets ownership and usage, 2006--2008 -- Annex 6. B. Household surveys of antimalarial treatment, 2006--2008 -- Annex 7. Funding for malaria control, 2008
  • The World Malaria Report 2012 summarizes information received from 104 malaria-endemic countries and other sources, and updates the analyses presented in the 2011 report. It highlights the progress made towards the global malaria targets set for 2015 and describes current challenges for global malaria control and elimination.
all 191 titles

Shortcut to Licensed Content

Lane Gateway to Licensed Content

Bookmark on other websites

Bookmark on Lane
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Links” (IE7) or “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page

Shortcut for iPhone

Lane Gateway to Licensed Content

  • Drag this button to your Safari bookmarks bar
  • Open iTunes and sync your iPhone; make sure "Sync Safari Bookmarks" under iPhone Info tab is selected
  • To invoke the bookmarklet on your iPhone, open Safari and tap the "Bookmarks" icon
  • Tap "Bookmarks Bar"
  • Tap "Lane Proxy Bookmarklet"

What is it?

This shortcut (Lane proxy bookmarklet) gives you access to resources licensed by the library even when you're not coming from a Lane or a Stanford IP address.

While we'd like Lane to be your gateway to our licensed content, we recognize that links to books, articles and journals come from a variety of different sources (Google, your email, RSS reader, etc.).

Lane Proxy Bookmarklet in the Bookmarks Bar
Up arrow

When installed, it will look your browser bookmark.

At the page you would like to proxy, click the "Lane Gateway to Licensed Content" to invoke it.

If Lane licenses that content, you'll get access as if you were on campus.

How does it work?

This shortcut (Lane proxy bookmarklet) is a combination of a browser bookmark and a JavaScript application. In other words, it's a bookmark that can be programmed to do things. The Lane proxy bookmarklet simply prepends the Lane proxy URL to the current URL in your browser.

This allows you to view the URL as though you were on campus, giving you access to materials licensed for use by the Stanford academic community.

If you're not authenticated, you'll be prompted for your SUNetID and password.

Don't see the Toolbar, Bookmarks, or Links or Favorites bar?

FireFox

From the "View" menu, select "Toolbars" & choose "Bookmarks Toolbar"

Safari

From the "View" menu, choose "Show Bookmarks Bar"

Chrome

From the "View" menu, choose "Always Show Bookmarks Bar"

Internet Explorer

IE controller bar
  • Right-click in a clear area near the browser address bar
  • In the menu, check a box next "Links" (IE7) or "Favorites" (IE8, IE9)
  • Managing IE Favorites

Caveats

This shortcut (Lane proxy bookmarklet) only works with resources Lane has licensed and configured to work with our proxy server.

If invoked on a resource we do not license and/or have not yet configured, you will see an error message:

The Lane proxy server cannot complete your request because this host has not been configured properly.

We make no attempt to configure our proxy server for every resource, only those we license and for which a Stanford IP address grants access.

Drag this button onto your browser toolbar to install.

  • Right click this button
  • Select "Add to Favorites", click "Continue" if you see a security alert
  • In "Create in" menu, select "Links" (IE7) or "Favorites Bar" (IE8, IE9) to install

Drag this button onto Safari Bookmarks bar to install.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities. In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more. Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.Provides one-click access to important clinical resources; includes evidence-based diagnosis and treatment guidelines, Books, EBM articles, Ovid MEDLINE, Drug facts and comparisons, Drug interaction facts, guidelines from National Guideline Clearinghouse, patient handouts (English and Spanish), and local content.MD consult provides access to textbooks, electronic journals, practice guidelines, drug information, and patient education handouts.A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.Provides online, full-text access to Springer's journal titles as well as journals from other publishers. Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.